0001193125-21-239407.txt : 20210806 0001193125-21-239407.hdr.sgml : 20210806 20210806170921 ACCESSION NUMBER: 0001193125-21-239407 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Equity Distribution Acquisition Corp. CENTRAL INDEX KEY: 0001818221 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39520 FILM NUMBER: 211153758 BUSINESS ADDRESS: STREET 1: TWO NORTH RIVERSIDE PLAZA, SUITE 600 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312.454.0100 MAIL ADDRESS: STREET 1: TWO NORTH RIVERSIDE PLAZA, SUITE 600 CITY: CHICAGO STATE: IL ZIP: 60606 10-Q 1 d198656d10q.htm 10-Q 10-Q
Table of Contents
P10DfalseEquity Distribution Acquisition Corp.0001818221Q2--12-31 0001818221 2021-06-30 0001818221 2020-12-31 0001818221 2021-04-01 2021-06-30 0001818221 2021-01-01 2021-06-30 0001818221 2021-01-01 2021-03-31 0001818221 2021-03-31 0001818221 us-gaap:CommonClassAMember 2021-06-30 0001818221 us-gaap:CommonClassBMember 2021-06-30 0001818221 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-06-30 0001818221 srt:MinimumMember eqd:ConditionToEffectBusinessCombinationMember 2021-06-30 0001818221 eqd:RestrictionOfShareTransferabilityOnApprovalOfBusinessCombinationMember srt:MaximumMember 2021-06-30 0001818221 srt:MaximumMember 2021-06-30 0001818221 srt:MinimumMember 2021-06-30 0001818221 eqd:SponsorMember 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember 2021-06-30 0001818221 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember eqd:PrivatePlacementWarantsMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceTwoMember 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceOneMember 2021-06-30 0001818221 us-gaap:CommonClassAMember eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceTwoMember 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001818221 us-gaap:FairValueInputsLevel2Member eqd:PrivateWarrantsMember 2021-06-30 0001818221 eqd:PrivatePlacementWarrantsMember 2021-06-30 0001818221 eqd:PublicWarrantsMember 2021-06-30 0001818221 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001818221 eqd:SponsorMember eqd:SecondPromissoryNoteMember 2021-06-30 0001818221 us-gaap:CommonClassAMember 2020-12-31 0001818221 us-gaap:CommonClassBMember 2020-12-31 0001818221 us-gaap:FairValueInputsLevel1Member eqd:PublicWarrantsMember 2020-12-31 0001818221 us-gaap:FairValueInputsLevel2Member eqd:PrivateWarrantsMember 2020-12-31 0001818221 eqd:PrivatePlacementWarrantsMember 2020-12-31 0001818221 eqd:PublicWarrantsMember 2020-12-31 0001818221 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001818221 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001818221 eqd:AffiliateOfSponsorMember eqd:AdministrativeSupportAgreementMember eqd:AccruedExpensesMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember eqd:MarketableSecuritiesHeldInTrustMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001818221 eqd:NonRedeemableCommonStockMember 2021-04-01 2021-06-30 0001818221 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 srt:MaximumMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001818221 eqd:AffiliateOfSponsorMember eqd:AdministrativeSupportAgreementMember eqd:AccruedExpensesMember 2021-01-01 2021-06-30 0001818221 eqd:SponsorMember 2021-01-01 2021-06-30 0001818221 us-gaap:CapitalUnitsMember 2021-01-01 2021-06-30 0001818221 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember eqd:MarketableSecuritiesHeldInTrustMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:NonRedeemableCommonStockMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceOneMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceTwoMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember eqd:ShareTriggerPriceTwoMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceTwoMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceOneMember 2021-01-01 2021-06-30 0001818221 srt:MinimumMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceOneMember srt:MinimumMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember eqd:ShareTriggerPriceOneMember srt:MaximumMember 2021-01-01 2021-06-30 0001818221 srt:MinimumMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001818221 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001818221 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-18 2020-09-18 0001818221 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2020-09-18 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember us-gaap:PrivatePlacementMember eqd:EquityDistributorSponsorLlcMember 2020-09-18 2020-09-18 0001818221 us-gaap:CommonClassAMember 2020-09-18 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember 2020-09-18 2020-09-18 0001818221 eqd:SponsorMember 2020-09-18 2020-09-18 0001818221 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember 2020-09-18 0001818221 us-gaap:IPOMember us-gaap:CommonClassAMember 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember us-gaap:PrivatePlacementMember eqd:EquityDistributorSponsorLlcMember 2020-09-18 0001818221 eqd:SponsorMember 2020-07-14 2020-07-14 0001818221 eqd:SponsorMember 2020-09-17 2020-09-17 0001818221 eqd:SponsorMember srt:MaximumMember 2020-06-30 2020-07-14 0001818221 eqd:SponsorMember 2020-06-30 2020-07-14 0001818221 eqd:SponsorMember us-gaap:CommonClassBMember 2020-06-30 2020-07-14 0001818221 eqd:SponsorMember srt:MinimumMember 2020-07-14 0001818221 eqd:SponsorMember 2020-07-14 0001818221 eqd:AffiliateOfSponsorMember eqd:AdministrativeSupportAgreementMember 2020-09-15 2020-09-15 0001818221 eqd:SponsorMember eqd:SecondPromissoryNoteMember 2021-06-29 0001818221 eqd:SponsorMember 2020-07-21 2020-07-21 0001818221 us-gaap:CommonClassAMember 2020-07-17 2020-12-31 0001818221 us-gaap:CommonClassBMember 2020-07-17 2020-12-31 0001818221 us-gaap:CommonClassAMember 2021-08-03 0001818221 us-gaap:CommonClassBMember 2021-08-03 0001818221 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember 2021-03-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001818221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001818221 us-gaap:RetainedEarningsMember 2021-06-30 0001818221 us-gaap:FairValueMeasurementsRecurringMember eqd:PrivatePlacementWarrantsMember 2020-12-31 0001818221 us-gaap:FairValueMeasurementsRecurringMember eqd:PublicWarrantsMember 2020-12-31 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001818221 eqd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-12-31 0001818221 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001818221 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001818221 us-gaap:RetainedEarningsMember 2020-12-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001818221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001818221 us-gaap:RetainedEarningsMember 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-03-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
        
    
    
to
    
        
    
    
Commission File
No. 001-39520
 
 
EQUITY DISTRIBUTION ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
85-1876561
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
Two North Riverside Plaza, Suite 600
Chicago, Illinois 60606
(Address of Principal Executive Offices, Zip Code)
(312)
466-4296
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange
on which registered
Units, each consisting of one share of Class A common stock and
one-third
of one redeemable warrant
 
EQD.U
 
New York Stock Exchange
Class A common stock, par value $0.0001 per share
 
EQD
 
New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
 
EQD WS
 
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    
Yes  ☐    
No
  ☒ 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes
  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer  
   Accelerated filer  
       
Non-accelerated filer  
   Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act):    Yes  
    No  ☐ 
As of August 3, 2021 there were
 
41,400,000
shares of Class A common stock, $0.0001 par value and
10,350,000
shares of Class B common stock, $0.0001 par value, issued and outstanding.
 
 
 

EQUITY DISTRIBUTION ACQUISITION CORP.
FORM
10-Q
FOR THE QUARTER ENDED JUNE 30, 2021
TABLE OF CONTENTS
 
 
  
 
  
Page
 
PART 1 – FINANCIAL INFORMATION
  
     
     
Item 1.
  
Financial Statements
  
     
     
 
  
  
 
1
 
     
 
  
  
 
2
 
     
 
  
  
 
3
 
     
 
  
  
 
4
 
     
 
  
  
 
5
 
     
Item 2.
  
  
 
14
 
     
Item 3.
  
  
 
16
 
     
Item 4.
  
  
 
16
 
   
  
     
     
Item 1.
  
  
 
16
 
     
Item 1A.
  
  
 
17
 
     
Item 2.
  
  
 
17
 
     
Item 3.
  
  
 
17
 
     
Item 4.
  
  
 
17
 
     
Item 5.
  
  
 
17
 
     
Item 6.
  
  
 
18
 
   
  
 
19
 
 
i

EQUITY DISTRIBUTION ACQUISITION CORP.
CONDENSED BALANCE SHEETS
 
    
June 30,
2021
    
December 31,
2020
 
    
(Unaudited)
        
ASSETS
                 
Current assets
                 
Cash
   $ 895,410      $ 882,702  
Prepaid expenses
     220,991        262,556  
    
 
 
    
 
 
 
Total Current Assets
     1,116,401        1,145,258  
Marketable securities held in Trust Account
     414,033,273        414,118,187  
    
 
 
    
 
 
 
TOTAL ASSETS
  
$
415,149,674
 
  
$
415,263,445
 
    
 
 
    
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
                 
Current
l
iabili
ty
,
 
a
ccrued expenses
   $ 1,060,317      $ 219,312  
Promissory note – related party
     750,000       
 
 
 
Warrant liability
     24,370,933        36,969,466  
Deferred underwriting fee payable
     14,490,000        14,490,000  
    
 
 
    
 
 
 
TOTAL LIABILITIES
  
 
40,671,250
 
  
 
51,678,778
 
    
 
 
    
 
 
 
Commitments and Contingencies
                 
Class A common stock subject to possible redemption 36,947,842 and 35,856,659 at redemption value as of June 30, 2021 and December 31, 2020, respectively
     369,478,420        358,584,662  
Stockholders’ Equity
                 
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
                   
Class A common stock, $0.0001 par value; 500,000,000 shares authorized; 4,452,158 and 5,543,341 shares issued and outstanding (excluding 36,947,842 and 35,856,659 shares subject to possible redemption) as of June 30, 2021 and December 31, 2020, respectively
     445        554  
Class B common stock, $0.0001 par value; 50,000,000 shares authorized; 10,350,000 shares issued and outstanding, as of June 30, 2021 and December 31, 2020, respectively
     1,035        1,035  
Additional
paid-in
capital
               7,699,371  
Retained earnings (accumulated deficit)
     4,998,524        (2,700,955
    
 
 
    
 
 
 
Total Stockholders’ Equity
  
 
5,000,004
 
  
 
5,000,005
 
    
 
 
    
 
 
 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
  
$
415,149,674
 
  
$
415,263,445
 
    
 
 
    
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
1

EQUITY DISTRIBUTION ACQUISITION CORP.
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
 
    
Three Months
Ended
June 30, 2021
   
Six Months
Ended

June 30, 2021
 
Operating and formation costs
   $ 546,257     $ 1,756,087  
    
 
 
   
 
 
 
Loss from operations
  
 
(546,257
 
 
(1,756,087
Other income (expense):
                
Interest earned on marketable securities held in Trust Account
     5,099       70,188  
Unrealized loss on marketable securities held in Trust Account
     (17,475     (17,475
Change in fair value of warrant liability
     (2,065,333     12,598,533  
    
 
 
   
 
 
 
Other (expense) income, net
     (2,077,709     12,651,246  
    
 
 
   
 
 
 
(Loss) Income before benefit from (provision for) income taxes
     (2,623,966     10,895,159  
Provision for income taxes
              (1,402
    
 
 
   
 
 
 
Net (loss) income
  
$
(2,623,966
 
$
10,893,757
 
    
 
 
   
 
 
 
Basic and diluted weighted average shares outstanding, Common st
o
ck subject to possible redemption
     37,210,238       36,405,265  
    
 
 
   
 
 
 
Basic and diluted net (loss) income per share, Common stock subject to possible redemption
  
$
(0.00
)  
$
0.00
 
    
 
 
   
 
 
 
Basic and diluted weighted average shares outstanding,
Non-redeemable
common stock
     14,539,762       15,212,812  
    
 
 
   
 
 
 
Basic and diluted net (loss) income per share,
Non-redeemable
common stock
  
$
(0.18
 
$
0.72
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
2

EQUITY DISTRIBUTION ACQUISITION CORP.
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
THREE AND SIX MONTHS ENDED JUNE 30, 2021
(Unaudited)
 
    
Class A

Common Stock
   
Class B

Common Stock
    
Additional

Paid-in

Capital
   
Retained
Earnings/
(Accumulated

Deficit)
   
Total

Stockholders’

Equity
 
    
Shares
   
Amount
   
Shares
    
Amount
 
Balance — January 1, 2021
  
 
5,543,341
 
 
$
554
 
 
 
10,350,000
 
  
$
1,035
 
  
$
7,699,371
 
 
$
(2,700,955
 
$
5,000,005
 
Change in value of Class A common stock subject to possible redemption
     (1,353,579     (135     —          —          (7,699,371     (5,818,212     (13,517,718
Net income
     —         —         —          —          —         13,517,723       13,517,723  
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance – March 31, 2021
  
 
4,189,762
 
 
$
419
 
 
 
10,350,000
 
  
$
1,035
 
  
$
—  
 
 
$
4,998,556
 
 
$
5,000,010
 
C
hange in value of Class A common stock subject to possible redemptio
n
     262,396       26       —          —          —         2,623,934       2,623,960  
Net loss
     —         —         —          —          —         (2,623,966     (2,623,966
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance – June 30, 202
1
  
 
4,452,158
 
 
$
445
 
 
 
10,350,000
 
  
$
1,035
 
  
$
—  
 
 
$
4,998,524
 
 
$
5,000,004
 
    
 
 
   
 
 
   
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
3

EQUITY DISTRIBUTION ACQUISITION CORP.
CONDENSED STATEMENT OF CASH FLOWS
SIX MONTHS ENDED JUNE 30, 2021
(Unaudited)
 
Cash Flows from Operating Activities:
        
Net income
   $ 10,893,757  
Adjustments to reconcile net income to net cash used in operating activities:
        
Interest earned on marketable securities held in Trust Account
     (70,188
Unrealized loss on marketable securities held in Trust Account
     17,475  
Change in fair value of warrant liability
     (12,598,533
Changes in operating assets and liabilities:
        
Prepaid expenses
     41,565  
Accrued expenses
     841,005  
    
 
 
 
Net cash used in operating activities
  
 
(874,919
Cash Flows from Investing Activities:
        
Cash withdrawn from Trust Account to pay franchise and income taxes
     137,627  
    
 
 
 
Net cash provided by investing activities
  
 
137,627
 
Cash Flows from Financing Activities:
        
Proceeds from promissory note – related party
     750,000  
    
 
 
 
Net cash provided by financing activities
  
 
750,000
 
Net Change in Cash
  
 
12,708
 
Cash – Beginning of period
     882,702  
    
 
 
 
Cash – End of period
  
$
895,410
 
    
 
 
 
Non-Cash
investing and financing activities:
        
Change in value of Class A common stock subject to possible redemption
   $ 10,893,758  
    
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
4

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
 
OPERATIONS
Equity Distribution Acquisition Corp. (the “Company”) was incorporated in Delaware on July 7, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”).
Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in North America that provide technology-enabled solutions in industrial and industrial distribution markets. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and the search for a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on September 15, 2020. On September 18, 2020, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note
4
.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,853,333 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Equity Distribution Sponsor, LLC (the “Sponsor”), generating gross proceeds of $10,280,000, which is described in Note
5
.
Transaction costs amounted to $23,411,063, consisting of
 
$8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $641,063 of other offering costs.
Following the closing of the Initial Public Offering on September 18, 2020, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule
2a-7
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote
 
5

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note
6
) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction or otherwise elects not to vote on the proposed transaction.
Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination by September 18, 2022 and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or
pre-initial
business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period (as defined below).
The Company will have until September 18, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note
7
) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
 
6

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
Risks and
 
Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty
.
NOTE 2
.
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
The Company determined that it had a classification error resulting in additional paid-in capital having a negative balance as of and for the three-month period ended March 31, 2021. This classification error is not material to the condensed financial statements and has been revised retroactively; the resulting change and the adjustments are as noted in the table below:​​​​​​​
 
 
  
As Previously
Reported
 
 
Adjustments
 
 
As Revised
 
Balance Sheet as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional paid-in capital
  
$
(5,818,212
 
$
5,818,212
 
 
$
 
Retained earnings (accumulated deficit)
  
 
10,816,768
 
 
 
(5,818,212
)
 
 
4,998,556
 
       
Statement of Changes in Stockholders’ Equity as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional Paid in Capital
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
(13,517,583
 
$
5,818,212
 
 
$
(7,699,371
)
Balance — March 31, 2021
  
 
(5,818,212
 
 
5,818,212
 
 
 
 
       
Retained Earnings/(Accumulated Deficit)
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
 
 
$
(5,818,212
)
 
$
(5,818,212
)
Balance — March 31, 2021
  
 
10,816,768
 
 
 
(5,818,212
 
 
4,998,556
 
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIE
S
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual report on Form
10-K/A
as filed with the SEC on May 24, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any other future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period
s
.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
 
7

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
Marketable Securities Held in Trust Account
At June 30, 2021 and at December 31,
 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses recognized through net income.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants (see Note
10
).
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
On March 27, 2020, the CARES Act was enacted in response to
COVID-19
pandemic. Under ASC Topic 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.
Net Income (Loss) per Common Share
Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the
two-class
method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 20,653,333 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period
s
presented.
Reconciliation of Net Income (Loss) per Common Share
Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,653,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
The Company’s statements of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the
two-class
method of income (loss) per share. Net income (loss) per share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Common stock subject to possible redemption outstanding since original issuance.
Net income (loss) per share, basic and diluted, for
non-redeemable
common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable
common stock outstanding for the period.
Non-redeemable
common stock includes Founder Shares and
non-redeemable
shares of common stock as these shares do not have any redemption features.
Non-redeemable
common stock participates in the income or loss on marketable securities based on
non-redeemable
shares’ proportionate interest.
 
8

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
 
    
Three Months
Ended
June 30,
    
Six Months
Ended
June 30,
 
    
2021
    
2021
 
Common stock subject to possible redemption
                 
Numerator: Earnings allocable to Class A common stock subject to possible redemption
                 
Interest earned on marketable securities held in Trust Account
   $ 4,551      $ 62,643  
Unrealized
loss
 on investments held in Trust Account
     (15,597      (15,597
Less: Interest available to be withdrawn for payment of taxes
               (47,046
    
 
 
    
 
 
 
Net (loss) income attributable
   $ (11,046    $  
    
 
 
    
 
 
 
Denominator: Weighted Average Common stock subject to possible redemption
                 
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption
     37,210,238        36,405,265  
 
 
 
 
 
 
 
 
 
Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption
   $ (0.00 )    $ 0.00  
    
 
 
    
 
 
 
                   
Non-Redeemable
Common Stock
                 
Numerator: Net
 
(
loss)
income minus Net Earnings
                 
Net (loss) income
   $ (2,623,966    $ 10,893,757  
Add: Net loss allocable to Class A common stock subject to possible redemption
     11,046         
    
 
 
    
 
 
 
Non-Redeemable
n
et (loss) income
   $ (2,612,920    $ 10,893,757  
    
 
 
    
 
 
 
Denominator: Weighted Average
Non-redeemable
common stock
                 
Basic and diluted weighted average shares outstanding,
Non-redeemable
common stock
     14,539,762        15,212,812  
 
 
 
 
 
 
 
 
 
Basic and diluted net
(
loss
) income
per share,
Non-redeemable
common stock
   $ (0.18    $ 0.72  
    
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of
 
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
NOTE
4
. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 5,400,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and
one-third
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 
9
).
NOTE
5
. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,853,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,280,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.
NOTE
6
. RELATED PARTY TRANSACTIONS
Founder Shares
On July 14, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 14,375,000 shares of Class B common stock (the “Founder Shares”). On July 21, 2020, the Company effected a
5-for-3
reverse stock split with respect to the Class B common stock and on September 17, 2020, the Company effected a
1-for-1.2
forward stock split, resulting in the initial stockholders holding an aggregate of 10,350,000 Founder Shares.
 
9

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
The Founder Shares included an aggregate of up to 1,350,000 shares of Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ election to fully exercise their over-allotment option, 1,350,000 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property.
Promissory Note — Related Party
On July 14, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was
non-interest
bearing and payable on the earlier of (i) January 31, 2021 or (ii) the consummation of the Initial Public Offering. The outstanding balance under the Promissory Note of $157,250 was repaid at the closing of the Initial Public Offering on September 18, 2020.
On June 29, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Second Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $2,500,000.
The Second Promissory Note was non-interest bearing and payable on the earlier of (i) September 18, 2022 or (ii) the consummation of the Initial Business Combination. As of June 30, 2021, the outstanding balance under the Second Promissory Note was 
$750,000
 and the remaining amount available to be drawn was $1,750,000
Administrative Support Agreement
The Company entered into an agreement, commencing on September 15, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space and administrative support services. For the three and six months ended June 30, 2021, the Company incurred and paid $30,000 and $60,000 in fees for these services, respectively.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.
NOTE
7
. COMMITMENTS AND CONTINGENCIES
Registration and Stockholders Rights Agreement
Pursuant to a registration and stockholders rights agreement entered into on September 18, 2020, the holders of the shares of common stock issued or issuable upon conversion of any Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights. Certain of the holders of these securities are entitled to make up to an aggregate of three demands that the Company register such securities, excluding short form demands. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. However, the registration and stockholders rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
10

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
Underwriting
 
Agreement
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $14,490,000 in the aggregate. Subject to the
 
terms of the underwriting agreement, (i) the deferred fee will be placed in the Trust Account and released to the underwriters only upon the completion of a Business Combination and (ii) the deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination. Up to 50% of the deferred underwriting commissions may be paid at the sole discretion of the Company’s management team to the underwriters in the allocations determined by the Company’s management team and/or to third parties not participating in the Initial Public Offering (but who are members of the Financial Industry Regulatory Authority) that assist the Company in consummating its initial Business Combination.
Legal Proceedings
From time to time, the Company is a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, the Company is not aware of any proceeding, threatened or pending, against the Company which, if determined adversely, would have a material effect on its business, results of operations, cash flows or financial position.
NOTE
8
. STOCKHOLDERS’ EQUITY
Preferred Stock
—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
—The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 4,452,158 and 5,543,341 shares of Class A common stock issued and outstanding, excluding 36,947,842 and 35,856,659 shares of Class A common stock subject to possible redemption, respectively.
Class
 B Common Stock
—The Company is authorized to issue 50,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 10,350,000 shares of Class B common stock issued and outstanding.
Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.
The shares of Class B common stock will automatically convert into shares of Class A common stock on the first business day following the completion of a Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, on an
as-converted
basis, 20% of the sum of (i) the total number of shares of Class A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of a Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of working capital loans. In no event will the shares of Class B common stock convert into shares of Class A common stock at a rate of less than one to one.
NOTE
9
. WARRANTS
Warrants
—Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement
 
11

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, it will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of warrants when the price per share of Class
 A common stock equals or exceeds $18.00.
Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants):
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the reported last reported sale price of the Class A common stock for any 20 trading days within a
30-trading
day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).
However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of our Class A common stock is available throughout the
30-day
redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per share of Class
 A common stock equals or exceeds $10.00.
Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:
 
   
in whole and not in part;
 
   
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;
 
   
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and
 
   
if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
 
12

EQUITY DISTRIBUTION ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2021
(Unaudited)
 
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A common (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
NOTE
10
. FAIR VALUE
 
MEASUREMENTS
The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are
re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that are
re-measured
and reported at fair value at least annually.
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
                   Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
    Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
    Level 3:    Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
    
June 30,
2021
    
December 31,
2020
 
Assets:
                          
Marketable securities held in Trust Account
     1      $ 414,033,273      $ 414,118,187  
Liabilities:
                          
Warrant Liability – Public Warrants
     1      $ 16,284,000      $ 24,702,000  
Warrant Liability – Private Warrants
     2      $ 8,086,933      $ 12,267,466  
The Warrants were accounted for as liabilities in accordance with
ASC 815-40
and are presented within warrant liabilities on our balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statements of operations. As of June 30, 2021 and December 31, 2020 the Public Warrants are classified as Level 1 due to the use of a quoted price in an active market. As of June 30, 2021 and December 31, 2020, the Private Placement Warrants are classified as Level 2 due to the use of a quoted price in an active market for a similar liability.
As of June 30, 2021, the Private Placement Warrants and Public Warrants were determined to be $1.18 per warrant for aggregate values of $8.1 million and $16.3 million, respectively.
As of December 31, 2020, the Private Placement Warrants and Public Warrants were determined to be $1.79 per warrant for aggregate values of $12.3 million and $24.7 million, respectively.
The following table presents the changes in the fair value of w
a
rrant liabilities:
 
    
Private Placement
    
Public
    
Warrant Liabilities
 
Fair value as of December 31, 2020
   $ 12,267,466      $ 24,702,000      $ 36,969,466  
Change in valuation inputs or other assumptions
     (4,180,533      (8,418,000      (12,598,533
    
 
 
    
 
 
    
 
 
 
Fair value as of June 30, 2021
   $ 8,086,933      $ 16,284,000      $ 24,370,933  
    
 
 
    
 
 
    
 
 
 
NOTE
11
. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
13

ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Equity Distribution Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors. References to the “Sponsor” refer to Equity Distribution Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual report on Form
10-K/A
filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at
www.sec.gov
. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company formed under the laws of the State of Delaware on July 7, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from July 7, 2020 (inception) through June 30, 2021 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and the search for a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We expect to generate
non-operating
income in the form of interest income on marketable securities held after the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended June 30, 2021, we had a net loss of $2,623,966, which consists of a change in the fair value of warrant liability of $2,065,333, operating costs of $546,257, which are comprised primarily of legal fees, consulting fees, printing fees and franchise taxes, as well as an unrealized loss on marketable securities held in Trust Account of $17,475, partially offset by interest income on marketable securities held in the Trust Account of $5,099.
For the six months ended June 30, 2021, we had net income of $10,893,757, which consists of a change in fair value of warrant liability of $12,598,533, and interest earned on marketable securities held in Trust Account of $70,188, partially offset by operating costs of $1,756,087, which are comprised primarily of legal fees, consulting fees, printing fees and franchise taxes, as well as an unrealized loss on marketable securities held in Trust Account of $17,475 and a provision for income taxes of $1,402.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B common stock by the Sponsor and loans from our Sponsor.
On September 18, 2020, we consummated the Initial Public Offering of 41,400,000 Units at a price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 5,400,000 Units, generating gross proceeds of $414,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 6,853,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant in a private placement to our Sponsor, generating gross proceeds of $10,280,000.
 
14

For the six months ended June 30, 2021, cash used in operating activities was $874,919. Net income of $10,893,757 was affected by the change in fair value of warrant liability of $12,598,533 and interest earned on marketable securities held in the Trust Account of $70,188 offset by an unrealized loss on marketable securities held in Trust Account of $17,475 and changes in operating assets and liabilities which provided $882,570 in cash from operating activities.
As of June 30, 2021, we had cash and marketable securities held in the Trust Account of $414,033,273. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account to complete our Business Combination. We may withdraw interest to pay franchise and income taxes. During the period ended June 30, 2021, cash withdrawn from the Trust Account to pay franchise and income taxes totaled $137,627. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2021, we had cash of $895,410 outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. The loans would be repaid upon consummation of a Business Combination, without interest.
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
Off-Balance
Sheet Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance
sheet arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating
off-balance
sheet arrangements. We have not entered into any
off-balance
sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any
non-financial
assets.
Contractual obligations
On June 29, 2021, we issued an unsecured promissory note to our Sponsor (the “Second Promissory Note”), pursuant to which, we may borrow up to an aggregate principal amount of $2,500,000. The Second Promissory Note is non-interest bearing and payable on the earlier of (i) September 18, 2022 or (ii) the consummation of the Initial Business Combination. As of June 30, 2021, the outstanding balance under the Second Promissory Note was $750,000 and the remaining amount available to be drawn was $1,750,000.
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the Second Promissory Note and an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for office space and administrative support to the Company. We began incurring these fees on September 15, 2020 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and the Company’s liquidation.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $14,490,000 in the aggregate. Subject to the terms of the underwriting agreement, (i) the deferred fee will be placed in the Trust Account and released to the underwriters only upon the completion of a Business Combination and (ii) the deferred fee will be waived by the underwriters in the event that we do not complete a Business Combination. Up to 50% of the deferred underwriting commissions may be paid at the sole discretion of its management team to the underwriters in the allocations determined by its management team and/or to third parties not participating in the Initial Public Offering (but who are members of the Financial Industry Regulatory Authority) that assist us in consummating its initial Business Combination.
 
15

Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Class A Common Stock Subject to Possible Redemption
We account for our shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of our unaudited condensed balance sheets.
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants.
Net Income (Loss) per Common Share
We apply the
two-class
method in calculating earnings per share. Net income (loss) per common share, basic and diluted for common stock subject to possible redemption is calculated by dividing the interest income earned on the Trust Account, net of applicable taxes, if any, by the weighted average number of shares of common stock subject to possible redemption outstanding for the period. Net income (loss) per common share, basic and diluted for and
non-redeemable
common stock is calculated by dividing net income (loss) less income attributable to common stock subject to possible redemption, by the weighted average number of shares of
non-redeemable
common stock outstanding for the period presented.
Recent accounting standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Following the consummation of our initial public offering, the net proceeds of our initial public offering, including amounts in our trust account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in U.S. treasury securities. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
 
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
As required by Rules
13a-15
and
15d-15
under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, solely due to the Company’s restatement of its financial statements to reclassify the Company’s Public Warrants and Private Placement Warrants as described in the Explanatory Note to our Form
10-K/A,
our disclosure controls and procedures were not effective as of June 30, 2021.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Restatement of Previously Issued Financial Statements
On May 11, 2021, we revised our prior position on accounting for warrants and concluded that our previously issued financial statements as of and for the period from July 7, 2020 (inception) through December 31, 2020 should not be relied on because of a misapplication in the guidance on warrant accounting. However, the
non-cash
adjustments to the financial statements do not impact the amounts previously reported for our cash or our investments held in the Trust Account.
Changes in Internal Control over Financial Reporting
Other than as noted below, there were no changes in our internal control over financial reporting (as such term is defined in Rules
13a-15(f)
and
15d-15(f)
of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. In light of the restatement of our financial statements included in our Form
10-K/A,
we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
PART II – OTHER INFORMATION
 
Item 1.
Legal Proceedings.
None.
 
16

Item 1A.
Risk Factors.
Factors that could cause our actual results to differ materially from those in this Quarterly Report include the risk factors described in our Annual report on Form
10-K/A
filed with the SEC on May 24, 2021. Except as disclosed, there have been no material changes to the risk factors disclosed in our Annual report on Form
10-K/A
for the year ended December 31, 2020.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
On September 18, 2020, we consummated the Initial Public Offering of 41,400,000 Units, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 5,400,000 Units. The Units sold in the Initial Public Offering were sold at an offering price of $10.00 per unit, generating total gross proceeds of $414,000,000. Credit Suisse Securities (USA) LLC acted as sole book-running manager. The securities in the offering were registered under the Securities Act on a registration statement on Form
S-1
(No.
333-248463
and
333-248829).
The Securities and Exchange Commission declared the registration statement effective on September 15, 2020.
Simultaneous with the consummation of the Initial Public Offering and the closing of the over-allotment option, we consummated the private placement of an aggregate of 6,853,333 warrants at a price of $1.50 per Private Placement Warrant, generating total proceed of $10,280,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.
Of the gross proceeds received from the Initial Public Offering, the closing of the over-allotment option and the Private Placement Warrants, $414,000,000 was placed in the Trust Account.
We paid a total of $8,280,000 in underwriting discounts and commissions and $641,063 for other offering costs related to the Initial Public Offering. In addition, the underwriters agreed to defer $14,490,000 in underwriting discounts and commissions.
 
Item 3.
Defaults Upon Senior Securities.
None.
 
Item 4.
Mine Safety Disclosures.
Not Applicable.
 
Item 5.
Other Information.
None.
 
17

Item 6.
Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form
10-Q.
 
No.
  
Description of Exhibit
31.1*   
31.2*   
32.1**   
32.2**   
101.INS*    Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    XBRL Taxonomy Extension Presentation Linkbase Document
104    The cover page from the Company’s Quarterly report on Form 10-Q for the quarter ended June 30, 2021 has been formatted in Inline XBRL and is included in Exhibits 101.
 
*
Filed herewith.
**
Furnished.
 
18

SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
EQUITY DISTRIBUTION ACQUISITION CORP.
Date: August 6, 2021
   
By:
 
/s/ William A. Galvin
   
Name:
 
William A. Galvin
   
Title:
 
Chief Executive Officer
     
(Principal Executive Officer)
Date: August 6, 2021
   
By:
 
/s/ Philip Tinkler
   
Name:
 
Philip Tinkler
   
Title:
 
Chief Financial Officer
     
(Principal Financial and Accounting Officer)
 
19
EX-31.1 2 d198656dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

Pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the

Securities Exchange Act of 1934

(Section 302 of the Sarbanes-Oxley Act of 2002)

I, William A. Galvin, certify that:

 

  1.

I have reviewed this Quarterly Report on Form 10-Q of Equity Distribution Acquisition Corp.;

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 6, 2021

   

By:

 

/s/ William A. Galvin

     

William A. Galvin

     

Chief Executive Officer and Director

     

(Principal Executive Officer)

EX-31.2 3 d198656dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

Pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the

Securities Exchange Act of 1934

(Section 302 of the Sarbanes-Oxley Act of 2002)

I, Philip Tinkler, certify that:

 

  1.

I have reviewed this Quarterly Report on Form 10-Q of Equity Distribution Acquisition Corp.;

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 6, 2021

   

By:

 

/s/ Philip Tinkler

     

Philip Tinkler

     

Chief Financial Officer

     

(Principal Financial and Accounting Officer)

EX-32.1 4 d198656dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Equity Distribution Acquisition Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, William A. Galvin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: August 6, 2021

   

By:

 

/s/ William A. Galvin

     

William A. Galvin

     

Chief Executive Officer

     

(Principal Executive Officer)

EX-32.2 5 d198656dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Equity Distribution Acquisition Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Philip Tinkler, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

  1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2.

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: August 6, 2021

   

By:

 

/s/ Philip Tinkler

     

Philip Tinkler

     

Chief Financial Officer

     

(Principal Financial and Accounting Officer)

EX-101.SCH 6 eqd-20210630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statement of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statement of Changes In Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Revision of Previously Issued Financial Statements link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Public Offering link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Revision of Previously Issued Financial Statements (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Private Placement - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 eqd-20210630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 eqd-20210630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 eqd-20210630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 eqd-20210630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 d198656d10q_htm.xml IDEA: XBRL DOCUMENT 0001818221 2021-06-30 0001818221 2020-12-31 0001818221 2021-04-01 2021-06-30 0001818221 2021-01-01 2021-06-30 0001818221 2021-01-01 2021-03-31 0001818221 2021-03-31 0001818221 us-gaap:CommonClassAMember 2021-06-30 0001818221 us-gaap:CommonClassBMember 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-06-30 0001818221 eqd:ConditionToEffectBusinessCombinationMember srt:MinimumMember 2021-06-30 0001818221 eqd:RestrictionOfShareTransferabilityOnApprovalOfBusinessCombinationMember srt:MaximumMember 2021-06-30 0001818221 srt:MaximumMember 2021-06-30 0001818221 srt:MinimumMember 2021-06-30 0001818221 eqd:SponsorMember 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember eqd:PrivatePlacementWarantsMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:ShareTriggerPriceTwoMember eqd:PrivatePlacementWarantsMember 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember eqd:PrivatePlacementWarantsMember 2021-06-30 0001818221 eqd:ShareTriggerPriceTwoMember eqd:PrivatePlacementWarantsMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember us-gaap:CommonClassAMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001818221 eqd:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001818221 eqd:PrivatePlacementWarrantsMember 2021-06-30 0001818221 eqd:PublicWarrantsMember 2021-06-30 0001818221 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001818221 eqd:SecondPromissoryNoteMember eqd:SponsorMember 2021-06-30 0001818221 us-gaap:CommonClassAMember 2020-12-31 0001818221 us-gaap:CommonClassBMember 2020-12-31 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001818221 eqd:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001818221 eqd:PrivatePlacementWarrantsMember 2020-12-31 0001818221 eqd:PublicWarrantsMember 2020-12-31 0001818221 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001818221 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001818221 eqd:AccruedExpensesMember eqd:AdministrativeSupportAgreementMember eqd:AffiliateOfSponsorMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember eqd:MarketableSecuritiesHeldInTrustMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember 2021-04-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001818221 eqd:NonRedeemableCommonStockMember 2021-04-01 2021-06-30 0001818221 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-01-01 2021-06-30 0001818221 srt:MaximumMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001818221 eqd:AccruedExpensesMember eqd:AdministrativeSupportAgreementMember eqd:AffiliateOfSponsorMember 2021-01-01 2021-06-30 0001818221 eqd:SponsorMember 2021-01-01 2021-06-30 0001818221 us-gaap:CapitalUnitsMember 2021-01-01 2021-06-30 0001818221 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember eqd:MarketableSecuritiesHeldInTrustMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember 2021-01-01 2021-06-30 0001818221 eqd:CommonStockSubjectToPossibleRedemptionMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:NonRedeemableCommonStockMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember eqd:PrivatePlacementWarantsMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceTwoMember eqd:PrivatePlacementWarantsMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceTwoMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceTwoMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 srt:MinimumMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember srt:MinimumMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 eqd:ShareTriggerPriceOneMember srt:MaximumMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 srt:MinimumMember eqd:PrivatePlacementWarantsMember 2021-01-01 2021-06-30 0001818221 eqd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2021-01-01 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001818221 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001818221 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-18 2020-09-18 0001818221 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-09-18 2020-09-18 0001818221 eqd:EquityDistributorSponsorLlcMember eqd:PrivatePlacementWarantsMember us-gaap:PrivatePlacementMember 2020-09-18 2020-09-18 0001818221 us-gaap:CommonClassAMember 2020-09-18 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember 2020-09-18 2020-09-18 0001818221 eqd:SponsorMember 2020-09-18 2020-09-18 0001818221 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-09-18 0001818221 eqd:PrivatePlacementWarantsMember 2020-09-18 0001818221 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-09-18 0001818221 eqd:EquityDistributorSponsorLlcMember eqd:PrivatePlacementWarantsMember us-gaap:PrivatePlacementMember 2020-09-18 0001818221 eqd:SponsorMember 2020-07-14 2020-07-14 0001818221 eqd:SponsorMember 2020-09-17 2020-09-17 0001818221 srt:MaximumMember eqd:SponsorMember 2020-06-30 2020-07-14 0001818221 eqd:SponsorMember 2020-06-30 2020-07-14 0001818221 eqd:SponsorMember us-gaap:CommonClassBMember 2020-06-30 2020-07-14 0001818221 srt:MinimumMember eqd:SponsorMember 2020-07-14 0001818221 eqd:SponsorMember 2020-07-14 0001818221 eqd:AdministrativeSupportAgreementMember eqd:AffiliateOfSponsorMember 2020-09-15 2020-09-15 0001818221 eqd:SecondPromissoryNoteMember eqd:SponsorMember 2021-06-29 0001818221 eqd:SponsorMember 2020-07-21 2020-07-21 0001818221 us-gaap:CommonClassAMember 2020-07-17 2020-12-31 0001818221 us-gaap:CommonClassBMember 2020-07-17 2020-12-31 0001818221 us-gaap:CommonClassAMember 2021-08-03 0001818221 us-gaap:CommonClassBMember 2021-08-03 0001818221 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember 2021-03-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001818221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001818221 us-gaap:RetainedEarningsMember 2021-06-30 0001818221 eqd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001818221 eqd:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 eqd:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001818221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001818221 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001818221 us-gaap:RetainedEarningsMember 2020-12-31 0001818221 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001818221 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001818221 us-gaap:RetainedEarningsMember 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001818221 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-03-31 0001818221 srt:RestatementAdjustmentMember us-gaap:RetainedEarningsMember 2021-03-31 iso4217:USD shares utr:Day pure utr:Year iso4217:USD shares P10D false Equity Distribution Acquisition Corp. 0001818221 Q2 --12-31 10-Q true 2021-06-30 2021 false 001-39520 DE 85-1876561 Two North Riverside Plaza Suite 600 Chicago IL 60606 312 466-4296 Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant EQD.U NYSE Class A common stock, par value $0.0001 per share EQD NYSE Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share EQD WS NYSE No Yes Non-accelerated Filer true true false true 41400000 10350000 895410 882702 220991 262556 1116401 1145258 414033273 414118187 415149674 415263445 1060317 219312 750000 24370933 36969466 14490000 14490000 40671250 51678778 36947842 35856659 369478420 358584662 0.0001 0.0001 1000000 1000000 0 0 0 0 0 0 0.0001 0.0001 500000000 500000000 4452158 4452158 5543341 5543341 36947842 35856659 445 554 0.0001 0.0001 50000000 50000000 10350000 10350000 10350000 10350000 1035 1035 0 7699371 4998524 -2700955 5000004 5000005 415149674 415263445 546257 1756087 -546257 -1756087 5099 70188 -17475 -17475 2065333 -12598533 -2077709 12651246 -2623966 10895159 0 1402 -2623966 10893757 37210238 36405265 0.00 0.00 14539762 15212812 -0.18 0.72 5543341 554 10350000 1035 7699371 -2700955 5000005 1353579 135 7699371 5818212 13517718 13517723 13517723 4189762 419 10350000 1035 4998556 5000010 -262396 -26 -2623934 -2623960 -2623966 -2623966 4452158 445 10350000 1035 4998524 5000004 10893757 70188 -17475 -12598533 -41565 841005 -874919 137627 137627 750000 750000 12708 882702 895410 10893758 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>OPERATIONS </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equity Distribution Acquisition Corp. (the “Company”) was incorporated in Delaware on July 7, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in North America that provide technology-enabled solutions in industrial and industrial distribution markets. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and the search for a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income from the proceeds derived from the Initial Public Offering. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company’s Initial Public Offering was declared effective on September 15, 2020. On September 18, 2020, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note <div style="display:inline;">4</div>. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,853,333 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Equity Distribution Sponsor, LLC (the “Sponsor”), generating gross proceeds of $10,280,000, which is described in Note <div style="display:inline;">5</div>. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs amounted to $23,411,063, consisting of<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>$8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $641,063 of other offering costs. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">Following the closing of the Initial Public Offering on September 18, 2020, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note <div style="display:inline;">6</div>) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction or otherwise elects not to vote on the proposed transaction. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination by September 18, 2022 and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-initial</div> business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period (as defined below). </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Company will have until September 18, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:hidden23717278">ten</span> business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note <div style="display:inline;">7</div>) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Uncertainties </div></div></div></div> <div style="text-align: justify; text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty<div style="display:inline;">.</div></div></div> 41400000 5400000 10.00 10.00 414000000 6853333 1.50 10280000 23411063 8280000 14490000 641063 414000000 10.00 P185D 0.80 0.50 10.00 5000001 0.15 2022-09-18 1 100000 10.00 10.00 <div style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 2<div style="letter-spacing: 0px; top: 0px;;display:inline;">.</div> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</div></div> </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:justify">The Company determined that it had a classification error resulting in additional paid-in capital having a negative balance as of and for the three-month period ended March 31, 2021. This classification error is not material to the condensed financial statements and has been revised retroactively; the resulting change and the adjustments are as noted in the table below:​​​​​​​ </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As Previously<br/> Reported</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As Revised</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance Sheet as of March 31, 2021 (Unaudited)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additional paid-in capital</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Retained earnings (accumulated deficit)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,816,768</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,998,556</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Statement of Changes in Stockholders’ Equity as of March 31, 2021 (Unaudited)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Additional Paid in Capital</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in value of Class A Common Stock Subject to Possible Redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(13,517,583</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(7,699,371</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance — March 31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Retained Earnings/(Accumulated Deficit)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in value of Class A Common Stock Subject to Possible Redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance — March 31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,816,768</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,998,556</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table> This classification error is not material to the condensed financial statements and has been revised retroactively; the resulting change and the adjustments are as noted in the table below:<div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As Previously<br/> Reported</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Adjustments</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As Revised</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance Sheet as of March 31, 2021 (Unaudited)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additional paid-in capital</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Retained earnings (accumulated deficit)</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,816,768</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">4,998,556</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Statement of Changes in Stockholders’ Equity as of March 31, 2021 (Unaudited)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Additional Paid in Capital</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in value of Class A Common Stock Subject to Possible Redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(13,517,583</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(7,699,371</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance — March 31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">—</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr> <tr style="font-size: 1pt;"> <td style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td> <td colspan="4" style="height: 12pt; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Retained Earnings/(Accumulated Deficit)</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td> <td style="vertical-align: bottom; font-family: 'Times New Roman';"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in value of Class A Common Stock Subject to Possible Redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(5,818,212</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: 'Times New Roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance — March 31, 2021</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,816,768</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5,818,212</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4,998,556</div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table> -5818212 5818212 10816768 -5818212 4998556 13517583 -5818212 7699371 -5818212 5818212 5818212 5818212 10816768 -5818212 4998556 <div style="font-family: 'Times New Roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: 'Times New Roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIE<div style="display:inline;">S</div></div></div></div></div> <div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> as filed with the SEC on May 24, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any other future periods. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Marketable Securities Held in Trust Account </div></div> <div style="text-align: justify; text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021 and at December 31,</div></div><div style="font-size: 10pt; letter-spacing: 0px; text-indent: 0px; top: 0px;;display:inline;"> 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses recognized through net income.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Common Stock Subject to Possible Redemption </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liability </div></div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants (see Note <div style="letter-spacing: 0px; top: 0px;;display:inline;">10</div>). </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">On March 27, 2020, the CARES Act was enacted in response to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. Under ASC Topic 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Common Share </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 20,653,333 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div> presented. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reconciliation of Net Income (Loss) per Common Share </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,653,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Company’s statements of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of income (loss) per share. Net income (loss) per share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">Net income (loss) per share, basic and diluted, for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> common stock outstanding for the period. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock includes Founder Shares and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares of common stock as these shares do not have any redemption features. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock participates in the income or loss on marketable securities based on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares’ proportionate interest. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Six Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common stock subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Numerator: Earnings allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,643</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized <div style="letter-spacing: 0px; top: 0px;;display:inline;">loss</div> on investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Interest available to be withdrawn for payment of taxes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(47,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income attributable</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Common stock subject to possible redemption</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,210,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,405,265</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 1pt;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 2pt; font-size: 2pt;"><div style="font-size: 2pt; line-height: 2pt;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">)</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Common Stock</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">loss)</div></div> income minus Net Earnings</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,623,966</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Add: Net loss allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,046</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal; text-align: justify;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">n</div>et (loss) income</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,612,920</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Denominator: Weighted Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">14,539,762</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">15,212,812</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-align: justify; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Basic and diluted net <div style="letter-spacing: 0px; top: 0px;;display:inline;">(</div>loss<div style="letter-spacing: 0px; top: 0px;;display:inline;">) income</div> per share, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.18</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.72</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 8 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K/A</div> as filed with the SEC on May 24, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any other future periods. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Marketable Securities Held in Trust Account </div></div> <div style="text-align: justify; text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021 and at December 31,</div></div><div style="font-size: 10pt; letter-spacing: 0px; text-indent: 0px; top: 0px;;display:inline;"> 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses recognized through net income.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Class A Common Stock Subject to Possible Redemption </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Liability </div></div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants (see Note <div style="letter-spacing: 0px; top: 0px;;display:inline;">10</div>). </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">On March 27, 2020, the CARES Act was enacted in response to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. Under ASC Topic 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements. </div> 0 0 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Common Share </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 20,653,333 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div> presented. </div> 20653333 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reconciliation of Net Income (Loss) per Common Share </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,653,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Company’s statements of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method of income (loss) per share. Net income (loss) per share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">Net income (loss) per share, basic and diluted, for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> common stock outstanding for the period. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock includes Founder Shares and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares of common stock as these shares do not have any redemption features. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock participates in the income or loss on marketable securities based on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> shares’ proportionate interest. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Six Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common stock subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Numerator: Earnings allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,643</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized <div style="letter-spacing: 0px; top: 0px;;display:inline;">loss</div> on investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Interest available to be withdrawn for payment of taxes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(47,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income attributable</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Common stock subject to possible redemption</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,210,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,405,265</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 1pt;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 2pt; font-size: 2pt;"><div style="font-size: 2pt; line-height: 2pt;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">)</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Common Stock</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">loss)</div></div> income minus Net Earnings</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,623,966</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Add: Net loss allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,046</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal; text-align: justify;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">n</div>et (loss) income</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,612,920</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Denominator: Weighted Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">14,539,762</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">15,212,812</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-align: justify; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Basic and diluted net <div style="letter-spacing: 0px; top: 0px;;display:inline;">(</div>loss<div style="letter-spacing: 0px; top: 0px;;display:inline;">) income</div> per share, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.18</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.72</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td></tr></table> 20653333 <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts): </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Three Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Six Months<br/> Ended</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Common stock subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Numerator: Earnings allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">62,643</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized <div style="letter-spacing: 0px; top: 0px;;display:inline;">loss</div> on investments held in Trust Account</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,597</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Interest available to be withdrawn for payment of taxes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(47,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income attributable</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(11,046</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Common stock subject to possible redemption</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">37,210,238</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,405,265</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px; line-height: 1pt;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-top: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 2pt; font-size: 2pt;"><div style="font-size: 2pt; line-height: 2pt;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="line-height: 2pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">(0.00</td> <td style="vertical-align: bottom; white-space: nowrap;">)</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;">$</td> <td style="vertical-align: bottom; white-space: nowrap; border-top: 0.75pt solid black;;text-align:right;">0.00</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Common Stock</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">loss)</div></div> income minus Net Earnings</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,623,966</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;">Add: Net loss allocable to Class A common stock subject to possible redemption</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,046</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">— </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal; text-align: justify;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> <div style="letter-spacing: 0px; top: 0px;;display:inline;">n</div>et (loss) income</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,612,920</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,893,757</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Denominator: Weighted Average <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Basic and diluted weighted average shares outstanding, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">14,539,762</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; border-bottom: 0.75pt solid black;;text-align:right;">15,212,812</td> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.75pt;"> </td></tr> <tr> <td style="vertical-align: top; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 1pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-align: justify; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; border-bottom: 0.75pt solid black;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; white-space: nowrap; line-height: 1pt; font-size: 1pt; padding-bottom: 0.75pt;"><div style="font-size: 1pt; line-height: 1pt;"><div style="font-size: 1pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal; text-align: justify;">Basic and diluted net <div style="letter-spacing: 0px; top: 0px;;display:inline;">(</div>loss<div style="letter-spacing: 0px; top: 0px;;display:inline;">) income</div> per share, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-redeemable</div> common stock</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.18</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.72</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td> <td><div style="line-height: normal;"> </div></td></tr></table> 4551 62643 -15597 -15597 0 -47046 -11046 37210238 36405265 0.00 0.00 -2623966 10893757 -11046 -2612920 10893757 14539762 15212812 -0.18 0.72 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Credit Risk </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div> 250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="letter-spacing: 0px; top: 0px;;display:inline;">4</div>. PUBLIC OFFERING </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 5,400,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note <div style="display:inline;">9</div>). </div> 41400000 5400000 10.00 10.00 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="letter-spacing: 0px; top: 0px;;display:inline;">5</div>. PRIVATE PLACEMENT </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,853,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,280,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants. </div></div> 6853333 1.50 10280000 1 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="letter-spacing: 0px; top: 0px;;display:inline;">6</div>. RELATED PARTY TRANSACTIONS </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Founder Shares </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">On July 14, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 14,375,000 shares of Class B common stock (the “Founder Shares”). On July 21, 2020, the Company effected a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5-for-3</div></div> reverse stock split with respect to the Class B common stock and on September 17, 2020, the Company effected a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-for-1.2</div></div> forward stock split, resulting in the initial stockholders holding an aggregate of 10,350,000 Founder Shares. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;">The Founder Shares included an aggregate of up to 1,350,000 shares of Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would own, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ election to fully exercise their over-allotment option, 1,350,000 Founder Shares are no longer subject to forfeiture. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Sponsor has agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Promissory Note — Related Party </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">On July 14, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing and payable on the earlier of (i) January 31, 2021 or (ii) the consummation of the Initial Public Offering. The outstanding balance under the Promissory Note of $157,250 was repaid at the closing of the Initial Public Offering on September 18, 2020. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">On June 29, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Second Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $2,500,000. <div style="letter-spacing: 0px; top: 0px;;display:inline;">The Second Promissory Note was non-interest bearing and payable on the earlier of (i) September 18, 2022 or (ii) the consummation of the Initial Business Combination. As of June 30, 2021, the outstanding balance under the Second Promissory Note was </div>$750,000<div style="letter-spacing: 0px; top: 0px;;display:inline;"> and the remaining amount available to be drawn was $1,750,000. </div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Administrative Support Agreement </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company entered into an agreement, commencing on September 15, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space and administrative support services. For the three and six months ended June 30, 2021, the Company incurred and paid $30,000 and $60,000 in fees for these services, respectively. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related Party Loans </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. </div></div> 25000 14375000 5-for-3 1-for-1.2 10350000 1350000 0.20 1350000 P1Y 12.00 P20D P30D P150D 300000 157250 2500000 750000 1750000 10000 30000 60000 1500000 1.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="letter-spacing: 0px; top: 0px;;display:inline;">7</div>. COMMITMENTS AND CONTINGENCIES </div></div></div></div> <div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration and Stockholders Rights Agreement </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to a registration and stockholders rights agreement entered into on September 18, 2020, the holders of the shares of common stock issued or issuable upon conversion of any Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights. Certain of the holders of these securities are entitled to make up to an aggregate of three demands that the Company register such securities, excluding short form demands. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. However, the registration and stockholders rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underwriting<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>Agreement </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters are entitled to a deferred fee of $0.35 per Unit, or $14,490,000 in the aggregate. Subject to the<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>terms of the underwriting agreement, (i) the deferred fee will be placed in the Trust Account and released to the underwriters only upon the completion of a Business Combination and (ii) the deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination. Up to 50% of the deferred underwriting commissions may be paid at the sole discretion of the Company’s management team to the underwriters in the allocations determined by the Company’s management team and/or to third parties not participating in the Initial Public Offering (but who are members of the Financial Industry Regulatory Authority) that assist the Company in consummating its initial Business Combination. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings </div></div></div></div> <div style="text-align: justify; text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, the Company is a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, the Company is not aware of any proceeding, threatened or pending, against the Company which, if determined adversely, would have a material effect on its business, results of operations, cash flows or financial position. </div></div></div> 0.35 14490000 0.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="display:inline;">8</div>. STOCKHOLDERS’ EQUITY </div></div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preferred Stock</div></div></div></div>—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Common Stock</div></div></div></div>—The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 4,452,158 and 5,543,341 shares of Class A common stock issued and outstanding, excluding 36,947,842 and 35,856,659 shares of Class A common stock subject to possible redemption, respectively. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B Common Stock</div></div></div></div>—The Company is authorized to issue 50,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 10,350,000 shares of Class B common stock issued and outstanding. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The shares of Class B common stock will automatically convert into shares of Class A common stock on the first business day following the completion of a Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, on an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as-converted</div> basis, 20% of the sum of (i) the total number of shares of Class A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of a Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of working capital loans. In no event will the shares of Class B common stock convert into shares of Class A common stock at a rate of less than one to one. </div> 1000000 1000000 0.0001 0.0001 0 0 0 0 500000000 500000000 0.0001 0.0001 one vote for each share one vote for each share 4452158 4452158 5543341 5543341 36947842 35856659 50000000 50000000 0.0001 0.0001 one vote for each share one vote for each share 10350000 10350000 10350000 10350000 0.20 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-align: justify;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="display:inline;">9</div>. WARRANTS </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants</div></div></div></div>—Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, it will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per share of Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A common stock equals or exceeds $18.00.</div></div> Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants): </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days’ prior written notice of redemption to each warrant holder; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;">if, and only if, the reported last reported sale price of the Class A common stock for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like). </div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of our Class A common stock is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per share of Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A common stock equals or exceeds $10.00.</div></div> Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 7%; text-align: justify;"> </td> <td style="width: 3%; vertical-align: top; text-align: justify;">•</td> <td style="width: 1%; vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: top;;text-align:left;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-align: justify;"/> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A common (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div> P5Y 18.00 0.01 P30D P20D P30D 18.00 10.00 0.10 P30D 10.00 18.00 9.20 0.60 P20D 9.20 1.15 10.00 18.00 1 1.80 P30D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="display:inline;">10</div>. FAIR VALUE<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div>MEASUREMENTS </div></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-align: justify;">The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at each reporting period, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-financial</div> assets and liabilities that are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measured</div> and reported at fair value at least annually. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="font-size: 0px;"> <td style="width: 7%; text-align: justify;"/> <td style="width: 1%; vertical-align: bottom; text-align: justify;"/> <td style="width: 7%; text-align: justify;"/> <td style="width: 1%; vertical-align: bottom; text-align: justify;"/> <td style="width: 84%; text-align: justify;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; text-align: justify;">                </td> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: top; text-align: justify;">Level 1:</td> <td style="vertical-align: bottom; text-align: justify;">  </td> <td style="vertical-align: top; text-align: justify;">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; text-align: justify;"> </td> <td colspan="2" style="height: 6pt; text-align: justify;"> </td> <td colspan="2" style="height: 6pt; text-align: justify;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: top; text-align: justify;">Level 2:</td> <td style="vertical-align: bottom; text-align: justify;">  </td> <td style="vertical-align: top; text-align: justify;">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</td> </tr> <tr style="font-size: 1pt;"> <td style="height: 6pt; text-align: justify;"> </td> <td colspan="2" style="height: 6pt; text-align: justify;"> </td> <td colspan="2" style="height: 6pt; text-align: justify;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; text-align: justify;"> </td> <td style="vertical-align: bottom; text-align: justify;"> </td> <td style="vertical-align: top; text-align: justify;">Level 3:</td> <td style="vertical-align: bottom; text-align: justify;">  </td> <td style="vertical-align: top; text-align: justify;">Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.</td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">414,033,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">414,118,187</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability – Public Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,284,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,702,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability – Private Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,086,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,267,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;">The Warrants were accounted for as liabilities in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 815-40</div> and are presented within warrant liabilities on our balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statements of operations. As of June 30, 2021 and December 31, 2020 the Public Warrants are classified as Level 1 due to the use of a quoted price in an active market. As of June 30, 2021 and December 31, 2020, the Private Placement Warrants are classified as Level 2 due to the use of a quoted price in an active market for a similar liability. </div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021, the Private Placement Warrants and Public Warrants were determined to be $1.18 per warrant for aggregate values of $8.1 million and $16.3 million, respectively. </div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2020, the Private Placement Warrants and Public Warrants were determined to be $1.79 per warrant for aggregate values of $12.3 million and $24.7 million, respectively. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of w<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>rrant liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,267,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,702,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,969,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,180,533</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,418,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,598,533</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,086,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,284,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,370,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 65%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 1pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,<br/> 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable securities held in Trust Account</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">414,033,273</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">414,118,187</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability – Public Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,284,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,702,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liability – Private Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,086,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,267,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> </table> 414033273 414118187 16284000 24702000 8086933 12267466 1.18 1.18 8100000 16300000 1.79 1.79 12300000 24700000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of w<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>rrant liabilities: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 54%;"/> <td style="width: 6%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant Liabilities</div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of December 31, 2020</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,267,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,702,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,969,466</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,180,533</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,418,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,598,533</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,086,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,284,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,370,933</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 12267466 24702000 36969466 -4180533 -8418000 -12598533 8086933 16284000 24370933 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTE <div style="display:inline;">11</div>. SUBSEQUENT EVENTS </div></div></div></div> <div style="text-align: justify; text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 12pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
6 Months Ended
Jun. 30, 2021
Aug. 03, 2021
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Entity Registrant Name Equity Distribution Acquisition Corp.  
Entity Central Index Key 0001818221  
Entity File Number 001-39520  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q2  
Entity Tax Identification Number 85-1876561  
Entity Incorporation, State or Country Code DE  
Entity Interactive Data Current Yes  
Current Fiscal Year End Date --12-31  
Document Period End Date Jun. 30, 2021  
Entity Current Reporting Status No  
Entity Address, State or Province IL  
Entity Shell Company true  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Title of 12(b) Security Class A common stock, par value $0.0001 per share  
Trading Symbol EQD  
Security Exchange Name NYSE  
Entity Address, Address Line One Two North Riverside Plaza  
Entity Address, Address Line Two Suite 600  
Entity Address, City or Town Chicago  
Entity Address, Postal Zip Code 60606  
City Area Code 312  
Local Phone Number 466-4296  
Capital Units [Member]    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant  
Trading Symbol EQD.U  
Security Exchange Name NYSE  
Warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share  
Trading Symbol EQD WS  
Security Exchange Name NYSE  
Common Class A [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   41,400,000
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   10,350,000
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 895,410 $ 882,702
Prepaid expenses 220,991 262,556
Total Current Assets 1,116,401 1,145,258
Marketable securities held in Trust Account 414,033,273 414,118,187
TOTAL ASSETS 415,149,674 415,263,445
Current liabilities    
Current liability, accrued expenses 1,060,317 219,312
Promissory note – related party 750,000  
Warrant liability 24,370,933 36,969,466
Deferred underwriting fee payable 14,490,000 14,490,000
TOTAL LIABILITIES 40,671,250 51,678,778
Commitments and Contingencies
Class A common stock subject to possible redemption 36,947,842 and 35,856,659 at redemption value as of June 30, 2021 and December 31, 2020, respectively 369,478,420 358,584,662
Stockholders' Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding 0 0
Additional paid-in capital 0 7,699,371
Retained earnings (accumulated deficit) 4,998,524 (2,700,955)
Total Stockholders' Equity 5,000,004 5,000,005
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 415,149,674 415,263,445
Common Class A [Member]    
Stockholders' Equity    
Common stock 445 554
Common Class B [Member]    
Stockholders' Equity    
Common stock $ 1,035 $ 1,035
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2021
Dec. 31, 2020
Preferred stock par value $ 0.0001 $ 0.0001
Preferred Stock Shares Authorized 1,000,000 1,000,000
Preferred Stock Shares Issued 0 0
Preferred stock outstanding 0 0
Common Class A [Member]    
Common stock subject to possible redemption 36,947,842 35,856,659
Common stock par value $ 0.0001 $ 0.0001
Common Stock Shares Authorized 500,000,000 500,000,000
Common Stock Shares Issued 4,452,158 5,543,341
Common Stock Shares Outstanding 4,452,158 5,543,341
Common Class B [Member]    
Common stock par value $ 0.0001 $ 0.0001
Common Stock Shares Authorized 50,000,000 50,000,000
Common Stock Shares Issued 10,350,000 10,350,000
Common Stock Shares Outstanding 10,350,000 10,350,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Income Statement [Abstract]    
Operating and formation costs $ 546,257 $ 1,756,087
Loss from operations (546,257) (1,756,087)
Other income (expense):    
Interest earned on marketable securities held in Trust Account 5,099 70,188
Unrealized loss on marketable securities held in Trust Account (17,475) (17,475)
Change in fair value of warrant liability (2,065,333) 12,598,533
Other (expense) income, net (2,077,709) 12,651,246
(Loss) Income before benefit from (provision for) income taxes (2,623,966) 10,895,159
Provision for income taxes 0 (1,402)
Net (loss) income $ (2,623,966) $ 10,893,757
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption 37,210,238 36,405,265
Basic and diluted net (loss) income per share, Common stock subject to possible redemption $ 0.00 $ 0.00
Basic and diluted weighted average shares outstanding, Non-redeemable common stock 14,539,762 15,212,812
Basic and diluted net (loss) income per share, Non-redeemable common stock $ (0.18) $ 0.72
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Changes In Stockholders' Equity - USD ($)
Total
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings/ (Accumulated Deficit) [Member]
Beginning balance at Dec. 31, 2020 $ 5,000,005 $ 554 $ 1,035 $ 7,699,371 $ (2,700,955)
Beginning balance, shares at Dec. 31, 2020   5,543,341 10,350,000    
Change in value of Class A common stock subject to possible redemption (13,517,718) $ (135)   (7,699,371) (5,818,212)
Change in value of Class A common stock subject to possible redemption, shares   (1,353,579)      
Net income (loss) 13,517,723       13,517,723
Ending balance at Mar. 31, 2021 5,000,010 $ 419 $ 1,035   4,998,556
Ending balance, shares at Mar. 31, 2021   4,189,762 10,350,000    
Beginning balance at Dec. 31, 2020 5,000,005 $ 554 $ 1,035 $ 7,699,371 (2,700,955)
Beginning balance, shares at Dec. 31, 2020   5,543,341 10,350,000    
Net income (loss) 10,893,757        
Ending balance at Jun. 30, 2021 5,000,004 $ 445 $ 1,035   4,998,524
Ending balance, shares at Jun. 30, 2021   4,452,158 10,350,000    
Beginning balance at Mar. 31, 2021 5,000,010 $ 419 $ 1,035   4,998,556
Beginning balance, shares at Mar. 31, 2021   4,189,762 10,350,000    
Change in value of Class A common stock subject to possible redemption 2,623,960 $ 26     2,623,934
Change in value of Class A common stock subject to possible redemption, shares   262,396      
Net income (loss) (2,623,966)       (2,623,966)
Ending balance at Jun. 30, 2021 $ 5,000,004 $ 445 $ 1,035   $ 4,998,524
Ending balance, shares at Jun. 30, 2021   4,452,158 10,350,000    
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Cash Flows from Operating Activities:    
Net income $ (2,623,966) $ 10,893,757
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account   (70,188)
Unrealized loss on marketable securities held in Trust Account   17,475
Change in fair value of warrant liability 2,065,333 (12,598,533)
Changes in operating assets and liabilities:    
Prepaid expenses   41,565
Accrued expenses   841,005
Net cash used in operating activities   (874,919)
Cash Flows from Investing Activities:    
Cash withdrawn from Trust Account to pay franchise and income taxes   137,627
Net cash provided by investing activities   137,627
Cash Flows from Financing Activities:    
Proceeds from promissory note – related party   750,000
Net cash provided by financing activities   750,000
Net Change in Cash   12,708
Cash – Beginning of period   882,702
Cash – End of period $ 895,410 895,410
Common Class A [Member]    
Non-Cash Investing and Financing Activities:    
Change in value of Class A common stock subject to possible redemption   $ 10,893,758
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Organization and Business Operations
6 Months Ended
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Organization and Business Operations
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
 
OPERATIONS
Equity Distribution Acquisition Corp. (the “Company”) was incorporated in Delaware on July 7, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”).
Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in North America that provide technology-enabled solutions in industrial and industrial distribution markets. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and the search for a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on September 15, 2020. On September 18, 2020, the Company consummated the Initial Public Offering of 41,400,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 5,400,000 Units, at $10.00 per Unit, generating gross proceeds of $414,000,000, which is described in Note
4
.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,853,333 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to Equity Distribution Sponsor, LLC (the “Sponsor”), generating gross proceeds of $10,280,000, which is described in Note
5
.
Transaction costs amounted to $23,411,063, consisting of
 
$8,280,000 of underwriting fees, $14,490,000 of deferred underwriting fees and $641,063 of other offering costs.
Following the closing of the Initial Public Offering on September 18, 2020, an amount of $414,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule
2a-7
of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote
for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note
6
) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares irrespective of whether it votes for or against the proposed transaction or otherwise elects not to vote on the proposed transaction.
Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination by September 18, 2022 and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or
pre-initial
business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period (as defined below).
The Company will have until September 18, 2022 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note
7
) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay the Company’s taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Risks and
 
Uncertainties
Management continues to evaluate the impact of the
COVID-19
pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty
.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Revision of Previously Issued Financial Statements
6 Months Ended
Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
Revision of Previously Issued Financial Statements
NOTE 2
.
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
The Company determined that it had a classification error resulting in additional paid-in capital having a negative balance as of and for the three-month period ended March 31, 2021. This classification error is not material to the condensed financial statements and has been revised retroactively; the resulting change and the adjustments are as noted in the table below:​​​​​​​
 
 
  
As Previously
Reported
 
 
Adjustments
 
 
As Revised
 
Balance Sheet as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional paid-in capital
  
$
(5,818,212
 
$
5,818,212
 
 
$
 
Retained earnings (accumulated deficit)
  
 
10,816,768
 
 
 
(5,818,212
)
 
 
4,998,556
 
       
Statement of Changes in Stockholders’ Equity as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional Paid in Capital
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
(13,517,583
 
$
5,818,212
 
 
$
(7,699,371
)
Balance — March 31, 2021
  
 
(5,818,212
 
 
5,818,212
 
 
 
 
       
Retained Earnings/(Accumulated Deficit)
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
 
 
$
(5,818,212
)
 
$
(5,818,212
)
Balance — March 31, 2021
  
 
10,816,768
 
 
 
(5,818,212
 
 
4,998,556
 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIE
S
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual report on Form
10-K/A
as filed with the SEC on May 24, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any other future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period
s
.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
At June 30, 2021 and at December 31,
 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses recognized through net income.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants (see Note
10
).
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
On March 27, 2020, the CARES Act was enacted in response to
COVID-19
pandemic. Under ASC Topic 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.
Net Income (Loss) per Common Share
Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the
two-class
method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 20,653,333 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period
s
presented.
Reconciliation of Net Income (Loss) per Common Share
Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,653,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
The Company’s statements of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the
two-class
method of income (loss) per share. Net income (loss) per share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Common stock subject to possible redemption outstanding since original issuance.
Net income (loss) per share, basic and diluted, for
non-redeemable
common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable
common stock outstanding for the period.
Non-redeemable
common stock includes Founder Shares and
non-redeemable
shares of common stock as these shares do not have any redemption features.
Non-redeemable
common stock participates in the income or loss on marketable securities based on
non-redeemable
shares’ proportionate interest.
The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
 
    
Three Months
Ended
June 30,
    
Six Months
Ended
June 30,
 
    
2021
    
2021
 
Common stock subject to possible redemption
                 
Numerator: Earnings allocable to Class A common stock subject to possible redemption
                 
Interest earned on marketable securities held in Trust Account
   $ 4,551      $ 62,643  
Unrealized
loss
 on investments held in Trust Account
     (15,597      (15,597
Less: Interest available to be withdrawn for payment of taxes
     —          (47,046
    
 
 
    
 
 
 
Net (loss) income attributable
   $ (11,046    $  
    
 
 
    
 
 
 
Denominator: Weighted Average Common stock subject to possible redemption
                 
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption
     37,210,238        36,405,265  
 
 
 
 
 
 
 
 
 
Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption
   $ (0.00 )    $ 0.00  
    
 
 
    
 
 
 
                   
Non-Redeemable
Common Stock
                 
Numerator: Net
 
(
loss)
income minus Net Earnings
                 
Net (loss) income
   $ (2,623,966    $ 10,893,757  
Add: Net loss allocable to Class A common stock subject to possible redemption
     11,046         
    
 
 
    
 
 
 
Non-Redeemable
n
et (loss) income
   $ (2,612,920    $ 10,893,757  
    
 
 
    
 
 
 
Denominator: Weighted Average
Non-redeemable
common stock
                 
Basic and diluted weighted average shares outstanding,
Non-redeemable
common stock
     14,539,762        15,212,812  
 
 
 
 
 
 
 
 
 
Basic and diluted net
(
loss
) income
per share,
Non-redeemable
common stock
   $ (0.18    $ 0.72  
    
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of
 
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Public Offering
6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Public Offering
NOTE
4
. PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 41,400,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 5,400,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and
one-third
of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 
9
).
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement
6 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Private Placement
NOTE
5
. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,853,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $10,280,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]  
Related Party Transactions
NOTE
6
. RELATED PARTY TRANSACTIONS
Founder Shares
On July 14, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 14,375,000 shares of Class B common stock (the “Founder Shares”). On July 21, 2020, the Company effected a
5-for-3
reverse stock split with respect to the Class B common stock and on September 17, 2020, the Company effected a
1-for-1.2
forward stock split, resulting in the initial stockholders holding an aggregate of 10,350,000 Founder Shares.
The Founder Shares included an aggregate of up to 1,350,000 shares of Class B common stock subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would own, on an
as-converted
basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ election to fully exercise their over-allotment option, 1,350,000 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, sold or released from escrow until the earlier of (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their common stock for cash, securities or other property.
Promissory Note — Related Party
On July 14, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note was
non-interest
bearing and payable on the earlier of (i) January 31, 2021 or (ii) the consummation of the Initial Public Offering. The outstanding balance under the Promissory Note of $157,250 was repaid at the closing of the Initial Public Offering on September 18, 2020.
On June 29, 2021, the Company issued an unsecured promissory note to the Sponsor (the “Second Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $2,500,000.
The Second Promissory Note was non-interest bearing and payable on the earlier of (i) September 18, 2022 or (ii) the consummation of the Initial Business Combination. As of June 30, 2021, the outstanding balance under the Second Promissory Note was 
$750,000
 and the remaining amount available to be drawn was $1,750,000. 
Administrative Support Agreement
The Company entered into an agreement, commencing on September 15, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space and administrative support services. For the three and six months ended June 30, 2021, the Company incurred and paid $30,000 and $60,000 in fees for these services, respectively.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
NOTE
7
. COMMITMENTS AND CONTINGENCIES
Registration and Stockholders Rights Agreement
Pursuant to a registration and stockholders rights agreement entered into on September 18, 2020, the holders of the shares of common stock issued or issuable upon conversion of any Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights. Certain of the holders of these securities are entitled to make up to an aggregate of three demands that the Company register such securities, excluding short form demands. In addition, the holders will have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. However, the registration and stockholders rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
Underwriting
 
Agreement
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $14,490,000 in the aggregate. Subject to the
 
terms of the underwriting agreement, (i) the deferred fee will be placed in the Trust Account and released to the underwriters only upon the completion of a Business Combination and (ii) the deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination. Up to 50% of the deferred underwriting commissions may be paid at the sole discretion of the Company’s management team to the underwriters in the allocations determined by the Company’s management team and/or to third parties not participating in the Initial Public Offering (but who are members of the Financial Industry Regulatory Authority) that assist the Company in consummating its initial Business Combination.
Legal Proceedings
From time to time, the Company is a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, the Company is not aware of any proceeding, threatened or pending, against the Company which, if determined adversely, would have a material effect on its business, results of operations, cash flows or financial position.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
NOTE
8
. STOCKHOLDERS’ EQUITY
Preferred Stock
—The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
—The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 4,452,158 and 5,543,341 shares of Class A common stock issued and outstanding, excluding 36,947,842 and 35,856,659 shares of Class A common stock subject to possible redemption, respectively.
Class
 B Common Stock
—The Company is authorized to issue 50,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. As of June 30, 2021 and December 31, 2020, there were 10,350,000 shares of Class B common stock issued and outstanding.
Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law.
The shares of Class B common stock will automatically convert into shares of Class A common stock on the first business day following the completion of a Business Combination at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, on an
as-converted
basis, 20% of the sum of (i) the total number of shares of Class A common stock issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the completion of a Business Combination, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of working capital loans. In no event will the shares of Class B common stock convert into shares of Class A common stock at a rate of less than one to one.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants
6 Months Ended
Jun. 30, 2021
Warrants [Abstract]  
Warrants
NOTE
9
. WARRANTS
Warrants
—Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement
covering the issuance of the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. In addition, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company elects to do so, it will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of warrants when the price per share of Class
 A common stock equals or exceeds $18.00.
Once the Public Warrants become exercisable, the Company may redeem the Public Warrants (except with respect to the Private Placement Warrants):
 
   
in whole and not in part;
 
   
at a price of $0.01 per warrant;
 
   
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
 
   
if, and only if, the reported last reported sale price of the Class A common stock for any 20 trading days within a
30-trading
day period ending three business days before the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).
However, in this case, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of our Class A common stock is available throughout the
30-day
redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of warrants when the price per share of Class
 A common stock equals or exceeds $10.00.
Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:
 
   
in whole and not in part;
 
   
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;
 
   
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like); and
 
   
if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A common (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be
non-redeemable
so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements
NOTE
10
. FAIR VALUE
 
MEASUREMENTS
The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are
re-measured
and reported at fair value at each reporting period, and
non-financial
assets and liabilities that are
re-measured
and reported at fair value at least annually.
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
                   Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
     
    Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
     
    Level 3:    Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
    
June 30,
2021
    
December 31,
2020
 
Assets:
                          
Marketable securities held in Trust Account
     1      $ 414,033,273      $ 414,118,187  
Liabilities:
                          
Warrant Liability – Public Warrants
     1      $ 16,284,000      $ 24,702,000  
Warrant Liability – Private Warrants
     2      $ 8,086,933      $ 12,267,466  
The Warrants were accounted for as liabilities in accordance with
ASC 815-40
and are presented within warrant liabilities on our balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statements of operations. As of June 30, 2021 and December 31, 2020 the Public Warrants are classified as Level 1 due to the use of a quoted price in an active market. As of June 30, 2021 and December 31, 2020, the Private Placement Warrants are classified as Level 2 due to the use of a quoted price in an active market for a similar liability.
As of June 30, 2021, the Private Placement Warrants and Public Warrants were determined to be $1.18 per warrant for aggregate values of $8.1 million and $16.3 million, respectively.
As of December 31, 2020, the Private Placement Warrants and Public Warrants were determined to be $1.79 per warrant for aggregate values of $12.3 million and $24.7 million, respectively.
The following table presents the changes in the fair value of w
a
rrant liabilities:
 
    
Private Placement
    
Public
    
Warrant Liabilities
 
Fair value as of December 31, 2020
   $ 12,267,466      $ 24,702,000      $ 36,969,466  
Change in valuation inputs or other assumptions
     (4,180,533      (8,418,000      (12,598,533
    
 
 
    
 
 
    
 
 
 
Fair value as of June 30, 2021
   $ 8,086,933      $ 16,284,000      $ 24,370,933  
    
 
 
    
 
 
    
 
 
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events
NOTE
11
. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual report on Form
10-K/A
as filed with the SEC on May 24, 2021. The interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any other future periods.
Emerging Growth Company
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period
s
.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
At June 30, 2021 and at December 31,
 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. The Company accounts for its securities held in the Trust Account in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 320 “Debt and Equity Securities.” These securities are classified as trading securities with unrealized gains/losses recognized through net income.
Class A Common Stock Subject to Possible Redemption
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.
Warrant Liability
Warrant Liability
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations. The fair value of the warrants was estimated using the publicly traded price of the Company’s warrants (see Note
10
).
Income Taxes
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
On March 27, 2020, the CARES Act was enacted in response to
COVID-19
pandemic. Under ASC Topic 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements.
Net Income (Loss) per Common Share
Net Income (Loss) per Common Share
Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the
two-class
method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net income (loss) per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 20,653,333 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants into shares of common stock is contingent upon the occurrence of future events. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the period
s
presented.
Reconciliation of Net Income (Loss) per Common Share
Reconciliation of Net Income (Loss) per Common Share
Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 20,653,333 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
The Company’s statements of operations include a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the
two-class
method of income (loss) per share. Net income (loss) per share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Common stock subject to possible redemption outstanding since original issuance.
Net income (loss) per share, basic and diluted, for
non-redeemable
common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of
non-redeemable
common stock outstanding for the period.
Non-redeemable
common stock includes Founder Shares and
non-redeemable
shares of common stock as these shares do not have any redemption features.
Non-redeemable
common stock participates in the income or loss on marketable securities based on
non-redeemable
shares’ proportionate interest.
The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
 
    
Three Months
Ended
June 30,
    
Six Months
Ended
June 30,
 
    
2021
    
2021
 
Common stock subject to possible redemption
                 
Numerator: Earnings allocable to Class A common stock subject to possible redemption
                 
Interest earned on marketable securities held in Trust Account
   $ 4,551      $ 62,643  
Unrealized
loss
 on investments held in Trust Account
     (15,597      (15,597
Less: Interest available to be withdrawn for payment of taxes
     —          (47,046
    
 
 
    
 
 
 
Net (loss) income attributable
   $ (11,046    $  
    
 
 
    
 
 
 
Denominator: Weighted Average Common stock subject to possible redemption
                 
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption
     37,210,238        36,405,265  
 
 
 
 
 
 
 
 
 
Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption
   $ (0.00 )    $ 0.00  
    
 
 
    
 
 
 
                   
Non-Redeemable
Common Stock
                 
Numerator: Net
 
(
loss)
income minus Net Earnings
                 
Net (loss) income
   $ (2,623,966    $ 10,893,757  
Add: Net loss allocable to Class A common stock subject to possible redemption
     11,046         
    
 
 
    
 
 
 
Non-Redeemable
n
et (loss) income
   $ (2,612,920    $ 10,893,757  
    
 
 
    
 
 
 
Denominator: Weighted Average
Non-redeemable
common stock
                 
Basic and diluted weighted average shares outstanding,
Non-redeemable
common stock
     14,539,762        15,212,812  
 
 
 
 
 
 
 
 
 
Basic and diluted net
(
loss
) income
per share,
Non-redeemable
common stock
   $ (0.18    $ 0.72  
    
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Concentration of Credit Risk
Concentration of
 
Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 825, “Financial Instruments,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Recent Accounting Standards
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Revision of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
Schedule Of Error Corrections And Prior Period Adjustments This classification error is not material to the condensed financial statements and has been revised retroactively; the resulting change and the adjustments are as noted in the table below:
 
 
  
As Previously
Reported
 
 
Adjustments
 
 
As Revised
 
Balance Sheet as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional paid-in capital
  
$
(5,818,212
 
$
5,818,212
 
 
$
 
Retained earnings (accumulated deficit)
  
 
10,816,768
 
 
 
(5,818,212
)
 
 
4,998,556
 
       
Statement of Changes in Stockholders’ Equity as of March 31, 2021 (Unaudited)
  
     
 
     
 
     
Additional Paid in Capital
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
(13,517,583
 
$
5,818,212
 
 
$
(7,699,371
)
Balance — March 31, 2021
  
 
(5,818,212
 
 
5,818,212
 
 
 
 
       
Retained Earnings/(Accumulated Deficit)
  
     
 
     
 
     
Change in value of Class A Common Stock Subject to Possible Redemption
  
$
 
 
$
(5,818,212
)
 
$
(5,818,212
)
Balance — March 31, 2021
  
 
10,816,768
 
 
 
(5,818,212
 
 
4,998,556
 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):
 
    
Three Months
Ended
June 30,
    
Six Months
Ended
June 30,
 
    
2021
    
2021
 
Common stock subject to possible redemption
                 
Numerator: Earnings allocable to Class A common stock subject to possible redemption
                 
Interest earned on marketable securities held in Trust Account
   $ 4,551      $ 62,643  
Unrealized
loss
 on investments held in Trust Account
     (15,597      (15,597
Less: Interest available to be withdrawn for payment of taxes
     —          (47,046
    
 
 
    
 
 
 
Net (loss) income attributable
   $ (11,046    $  
    
 
 
    
 
 
 
Denominator: Weighted Average Common stock subject to possible redemption
                 
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption
     37,210,238        36,405,265  
 
 
 
 
 
 
 
 
 
Basic and diluted net (loss) income per share, Class A common stock subject to possible redemption
   $ (0.00 )    $ 0.00  
    
 
 
    
 
 
 
                   
Non-Redeemable
Common Stock
                 
Numerator: Net
 
(
loss)
income minus Net Earnings
                 
Net (loss) income
   $ (2,623,966    $ 10,893,757  
Add: Net loss allocable to Class A common stock subject to possible redemption
     11,046         
    
 
 
    
 
 
 
Non-Redeemable
n
et (loss) income
   $ (2,612,920    $ 10,893,757  
    
 
 
    
 
 
 
Denominator: Weighted Average
Non-redeemable
common stock
                 
Basic and diluted weighted average shares outstanding,
Non-redeemable
common stock
     14,539,762        15,212,812  
 
 
 
 
 
 
 
 
 
Basic and diluted net
(
loss
) income
per share,
Non-redeemable
common stock
   $ (0.18    $ 0.72  
    
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021 and at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
  
Level
    
June 30,
2021
    
December 31,
2020
 
Assets:
                          
Marketable securities held in Trust Account
     1      $ 414,033,273      $ 414,118,187  
Liabilities:
                          
Warrant Liability – Public Warrants
     1      $ 16,284,000      $ 24,702,000  
Warrant Liability – Private Warrants
     2      $ 8,086,933      $ 12,267,466  
Summary of Reconciliation of Warrant Liabilities Measured at Fair Value
The following table presents the changes in the fair value of w
a
rrant liabilities:
 
    
Private Placement
    
Public
    
Warrant Liabilities
 
Fair value as of December 31, 2020
   $ 12,267,466      $ 24,702,000      $ 36,969,466  
Change in valuation inputs or other assumptions
     (4,180,533      (8,418,000      (12,598,533
    
 
 
    
 
 
    
 
 
 
Fair value as of June 30, 2021
   $ 8,086,933      $ 16,284,000      $ 24,370,933  
    
 
 
    
 
 
    
 
 
 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Organization and Business Operations - Additional Information (Detail) - USD ($)
6 Months Ended
Sep. 18, 2020
Jun. 30, 2021
Nature Of Organisation [Line Items]    
Percentage of the total public shares transferrable   15.00%
Date before which the business combination is to be consumated   Sep. 18, 2022
Percentage of public shares due to be redeemed on non occurrence of business combination   100.00%
Number of business days after the expiry date within which public shares shall be redeemed   10 days
Estimated liquidation expenses payable   $ 100,000
Maximum [Member]    
Nature Of Organisation [Line Items]    
Restricted investments term   185 days
Per share amount of assets available for distribution   $ 10.00
Maximum [Member] | Restriction Of Share Transferability On Approval Of Business Combination [Member]    
Nature Of Organisation [Line Items]    
Estimated minimum networth of the combined companies post business combination   $ 5,000,001
Minimum [Member]    
Nature Of Organisation [Line Items]    
Per share amount of assets available for distribution   $ 10.00
Minimum [Member] | Condition To Effect Business Combination [Member]    
Nature Of Organisation [Line Items]    
Percentage of the fair value of the amount held in trust account excluding deferred underwriting commissions and income taxes   80.00%
Equity method investment ownership percentage   50.00%
Redemption value per share,common stock   $ 10.00
Common Class A [Member]    
Nature Of Organisation [Line Items]    
Proceeds from initial public offer $ 414,000,000  
Common Class A [Member] | IPO [Member]    
Nature Of Organisation [Line Items]    
Stock shares issued during the period shares new issues 41,400,000 41,400,000
Sale of stock issue price per share $ 10.00 $ 10.00
Stock issuance costs   $ 23,411,063
Undrwriting fees   8,280,000
Deferred underwriting fees payable non current   14,490,000
Other offering costs   $ 641,063
Common Class A [Member] | Over-Allotment Option [Member]    
Nature Of Organisation [Line Items]    
Stock shares issued during the period shares new issues 5,400,000 5,400,000
Sale of stock issue price per share $ 10.00 $ 10.00
Private Placement Warants [Member]    
Nature Of Organisation [Line Items]    
Sale of stock issue price per share $ 10.00  
Payment towards restricted investments $ 414,000,000  
Private Placement Warants [Member] | Private Placement [Member] | Equity Distributor Sponsor LLC [Member]    
Nature Of Organisation [Line Items]    
Stock shares issued during the period shares new issues 6,853,333  
Class of warrants or rights issue price per share $ 1.50  
Proceeds From issue of warrants $ 10,280,000  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail) - USD ($)
3 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]      
Additional paid-in capital $ 0   $ 7,699,371
Retained earnings (accumulated deficit) 4,998,524 $ 4,998,556 $ (2,700,955)
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption 2,623,960 (13,517,718)  
Ending balance 5,000,004 5,000,010  
Additional Paid-in Capital [Member]      
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption   (7,699,371)  
Retained Earnings/ (Accumulated Deficit) [Member]      
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption 2,623,934 (5,818,212)  
Ending balance $ 4,998,524 4,998,556  
Previously Reported [Member]      
Statement of Financial Position [Abstract]      
Additional paid-in capital   (5,818,212)  
Retained earnings (accumulated deficit)   10,816,768  
Previously Reported [Member] | Additional Paid-in Capital [Member]      
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption   (13,517,583)  
Ending balance   (5,818,212)  
Previously Reported [Member] | Retained Earnings/ (Accumulated Deficit) [Member]      
Statement of Stockholders' Equity [Abstract]      
Ending balance   10,816,768  
Revision of Prior Period, Adjustment [Member]      
Statement of Financial Position [Abstract]      
Additional paid-in capital   5,818,212  
Retained earnings (accumulated deficit)   (5,818,212)  
Revision of Prior Period, Adjustment [Member] | Additional Paid-in Capital [Member]      
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption   5,818,212  
Ending balance   5,818,212  
Revision of Prior Period, Adjustment [Member] | Retained Earnings/ (Accumulated Deficit) [Member]      
Statement of Stockholders' Equity [Abstract]      
Change in value of Class A common stock subject to possible redemption   (5,818,212)  
Ending balance   $ (5,818,212)  
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Numerator: Earnings allocable to Class A common stock subject to possible redemption      
Interest earned on marketable securities held in Trust Account $ 5,099   $ 70,188
Denominator: Weighted Average Common stock subject to possible redemption      
Basic and diluted weighted average shares outstanding 14,539,762   15,212,812
Basic and diluted net income (loss) per share $ (0.18)   $ 0.72
Numerator: Net (loss) income minus Net Earnings      
Net (loss) income $ (2,623,966) $ 13,517,723 $ 10,893,757
Non Redeemable Common Stock [Member]      
Denominator: Weighted Average Common stock subject to possible redemption      
Basic and diluted weighted average shares outstanding 14,539,762   15,212,812
Basic and diluted net income (loss) per share $ (0.18)   $ 0.72
Numerator: Net (loss) income minus Net Earnings      
Net (loss) income $ (2,623,966)   $ 10,893,757
Non-Redeemable net (loss) income (2,612,920)   10,893,757
Common Stock Subject To Possible Redemption [Member]      
Numerator: Earnings allocable to Class A common stock subject to possible redemption      
Unrealized loss on investments held in Trust Account (15,597)   (15,597)
Less: Interest available to be withdrawn for payment of taxes 0   (47,046)
Net (loss) income attributable (11,046)  
Numerator: Net (loss) income minus Net Earnings      
Add: Net loss allocable to Class A common stock subject to possible redemption 11,046  
Common Stock Subject To Possible Redemption [Member] | Common Class A [Member]      
Numerator: Earnings allocable to Class A common stock subject to possible redemption      
Net (loss) income attributable $ (11,046)  
Denominator: Weighted Average Common stock subject to possible redemption      
Basic and diluted weighted average shares outstanding 37,210,238   36,405,265
Basic and diluted net income (loss) per share $ 0.00   $ 0.00
Numerator: Net (loss) income minus Net Earnings      
Add: Net loss allocable to Class A common stock subject to possible redemption $ 11,046  
Common Stock Subject To Possible Redemption [Member] | Marketable Securities Held In Trust [Member]      
Numerator: Earnings allocable to Class A common stock subject to possible redemption      
Interest earned on marketable securities held in Trust Account $ 4,551   $ 62,643
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Significant Accounting Policies [Line Items]    
Unrecognised tax liabilities $ 0 $ 0
Unrecognised tax liabilities accrued penalties and interest $ 0 $ 0
Antidilutive securities excluded from the computation of earnings per share 20,653,333  
Cash insured with federal insurance $ 250,000  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Public Offering - Additional Information (Detail) - $ / shares
6 Months Ended
Sep. 18, 2020
Jun. 30, 2021
Dec. 31, 2020
IPO [Member] | Common Class A [Member]      
Disclosure Of Public Offering [Line Items]      
Stock shares issued during the period shares new issues 41,400,000 41,400,000  
Sale of stock issue price per share $ 10.00 $ 10.00  
Over-Allotment Option [Member] | Common Class A [Member]      
Disclosure Of Public Offering [Line Items]      
Stock shares issued during the period shares new issues 5,400,000 5,400,000  
Sale of stock issue price per share $ 10.00 $ 10.00  
Public Warrants [Member]      
Disclosure Of Public Offering [Line Items]      
Excerice price of warrants   1.18 $ 1.79
Public Warrants [Member] | Common Class A [Member]      
Disclosure Of Public Offering [Line Items]      
Excerice price of warrants   $ 11.50  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement - Additional Information (Detail) - Private Placement Warants [Member]
6 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Disclosure Of Private Placement [Line Items]  
Class of warrant or right, price per warrant | $ / shares $ 1.50
Stock related warrants issued during the period shares | shares 6,853,333
Stock related warrants issued during the period value | $ $ 10,280,000
Excerice price of warrants | $ / shares $ 11.50
Number Of Securities Called By Each Warrant | shares 1
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Sep. 18, 2020
Sep. 17, 2020
Sep. 15, 2020
Jul. 21, 2020
Jul. 14, 2020
Jul. 14, 2020
Jun. 30, 2021
Jun. 30, 2021
Jun. 29, 2021
Related Party Transaction [Line Items]                  
Promissory note – related party             $ 750,000 $ 750,000  
Sponsor [Member]                  
Related Party Transaction [Line Items]                  
Stock issued during the period value for services         $ 25,000        
Stock issued during the period shares issued for shares         14,375,000        
Reserve stock split ratio       5-for-3          
Stock split ratio   1-for-1.2              
Lock in period of shareholding           1 year      
Share transfer restriction, threshold consecutive trading days           20 days      
Share transfer restriction, threshold trading days           30 days      
Number of days for a particular event to get over for determning trading period           150 days      
Debt face value         $ 300,000 $ 300,000      
Repayment of notes payable $ 157,250                
Conversion of debt into warrants value               $ 1,500,000  
Converion price per unit of debt into warrant             $ 1.50 $ 1.50  
Stock issued during the period shares Stock Splits   10,350,000              
Sponsor [Member] | Common Class B [Member]                  
Related Party Transaction [Line Items]                  
Common Stock Subject To Repurchase Or Cancellation           1,350,000      
Sponsor [Member] | Maximum [Member]                  
Related Party Transaction [Line Items]                  
Percentage of common stock shareholding           20.00%      
Sponsor [Member] | Minimum [Member]                  
Related Party Transaction [Line Items]                  
Share price         $ 12.00 $ 12.00      
Sponsor [Member] | Second Promissory Note [Member]                  
Related Party Transaction [Line Items]                  
Debt face value                 $ 2,500,000
Promissory note – related party             $ 750,000 $ 750,000  
Debt instrument unused borrowing capacity                 $ 1,750,000
Affiliate Of Sponsor [Member] | Administrative Support Agreement [Member]                  
Related Party Transaction [Line Items]                  
Related party transaction amounts of transaction     $ 10,000            
Affiliate Of Sponsor [Member] | Administrative Support Agreement [Member] | Accrued Expenses [Member]                  
Related Party Transaction [Line Items]                  
Related party transaction amounts of transaction             $ 30,000 $ 60,000  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments and Contingencies - Additional Information (Detail)
Jun. 30, 2021
USD ($)
$ / shares
Commitments and Contingencies Disclosure [Abstract]  
Underwriting fee, per unit | $ / shares $ 0.35
Deferred underwriting fees payable | $ $ 14,490,000
Deferred underwriting commissions percentage payable 50.00%
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity - Additional Information (Detail) - $ / shares
5 Months Ended 6 Months Ended
Dec. 31, 2020
Jun. 30, 2021
Class of Stock [Line Items]    
Preferred stock Par value $ 0.0001 $ 0.0001
Preferred stock Authorized 1,000,000 1,000,000
Preferred stock issued 0 0
Preferred stock Outstanding 0 0
Common Class A [Member]    
Class of Stock [Line Items]    
Common stock par value $ 0.0001 $ 0.0001
Common stock Authorized 500,000,000 500,000,000
Common stock issued 5,543,341 4,452,158
Common stock Outstanding 5,543,341 4,452,158
Ordinary shares subject to possible redemption shares 35,856,659 36,947,842
Common stock description of voting rights one vote for each share one vote for each share
Common Class B [Member]    
Class of Stock [Line Items]    
Common stock par value $ 0.0001 $ 0.0001
Common stock Authorized 50,000,000 50,000,000
Common stock issued 10,350,000 10,350,000
Common stock Outstanding 10,350,000 10,350,000
Common stock description of voting rights one vote for each share one vote for each share
Minimum common stock shares to be maintained   20.00%
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants - Additional Information (Detail)
6 Months Ended
Jun. 30, 2021
$ / shares
Class of Warrant or Right [Line Items]  
Public warrants expiry period 5 years
Percentage of proceeds from share issuances 60.00%
Number of days untill which warrants will not become transferable or salable 30 days
Minimum [Member]  
Class of Warrant or Right [Line Items]  
Warrants redeemable,threshold consecutive trading days 20 days
Private Placement Warants [Member] | Minimum [Member]  
Class of Warrant or Right [Line Items]  
Class of warrants exercise price adjustment percentage 115.00%
Private Placement Warants [Member] | Share Trigger Price One [Member]  
Class of Warrant or Right [Line Items]  
Warrants, redemption price per share $ 0.01
Minimum notice period for warrants redemption 30 days
Private Placement Warants [Member] | Share Trigger Price One [Member] | Maximum [Member]  
Class of Warrant or Right [Line Items]  
Warrants redeemable,threshold consecutive trading days 30 days
Class of warrants exercise price adjustment percentage 180.00%
Private Placement Warants [Member] | Share Trigger Price One [Member] | Minimum [Member]  
Class of Warrant or Right [Line Items]  
Warrants redeemable,threshold consecutive trading days 20 days
Class of warrants exercise price adjustment percentage 100.00%
Private Placement Warants [Member] | Share Trigger Price Two [Member]  
Class of Warrant or Right [Line Items]  
Warrants, redemption price per share $ 0.10
Minimum notice period for warrants redemption 30 days
Common Class A [Member]  
Class of Warrant or Right [Line Items]  
Business acquisition, share price $ 9.20
Common Class A [Member] | Share Trigger Price One [Member]  
Class of Warrant or Right [Line Items]  
Business acquisition, share price 9.20
Common Class A [Member] | Share Trigger Price Two [Member]  
Class of Warrant or Right [Line Items]  
Minimum share price required for redemption of warrants 18.00
Common Class A [Member] | Private Placement Warants [Member] | Share Trigger Price One [Member]  
Class of Warrant or Right [Line Items]  
Minimum share price required for redemption of warrants 18.00
Warrants, redemption price per share 10.00
Common Class A [Member] | Private Placement Warants [Member] | Share Trigger Price Two [Member]  
Class of Warrant or Right [Line Items]  
Minimum share price required for redemption of warrants 18.00
Warrants, redemption price per share $ 10.00
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Liabilities, Fair Value Disclosure [Abstract]    
Warrant Liability $ 24,370,933 $ 36,969,466
Fair Value, Inputs, Level 1 [Member]    
Assets:    
Marketable securities held in Trust Account 414,033,273 414,118,187
Fair Value, Inputs, Level 1 [Member] | Public Warrants [Member]    
Liabilities, Fair Value Disclosure [Abstract]    
Warrant Liability 16,284,000 24,702,000
Fair Value, Inputs, Level 2 [Member] | Private Warrants [Member]    
Liabilities, Fair Value Disclosure [Abstract]    
Warrant Liability $ 8,086,933 $ 12,267,466
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail) - Fair Value, Recurring [Member]
6 Months Ended
Jun. 30, 2021
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Fair value as of December 31, 2020 $ 36,969,466
Change in valuation inputs or other assumptions (12,598,533)
Fair value as of June 30, 2021 24,370,933
Private Placement Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Fair value as of December 31, 2020 12,267,466
Change in valuation inputs or other assumptions (4,180,533)
Fair value as of June 30, 2021 8,086,933
Public Warrants [Member]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Fair value as of December 31, 2020 24,702,000
Change in valuation inputs or other assumptions (8,418,000)
Fair value as of June 30, 2021 $ 16,284,000
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
Jun. 30, 2021
Dec. 31, 2020
Private Placement Warrants [Member]    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Warrants exercise price per share $ 1.18 $ 1.79
Warrants outstanding $ 8.1 $ 12.3
Public Warrants [Member]    
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]    
Warrants exercise price per share $ 1.18 $ 1.79
Warrants outstanding $ 16.3 $ 24.7
EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 47 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 120 249 1 false 35 0 false 6 false false R1.htm 1001 - Document - Cover Page Sheet http://equ.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://equ.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://equ.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statement of Operations Sheet http://equ.com/role/CondensedStatementOfOperations Condensed Statement of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statement of Changes In Stockholders' Equity Sheet http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity Condensed Statement of Changes In Stockholders' Equity Statements 5 false false R6.htm 1006 - Statement - Condensed Statement of Cash Flows Sheet http://equ.com/role/CondensedStatementOfCashFlows Condensed Statement of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization and Business Operations Sheet http://equ.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Revision of Previously Issued Financial Statements Sheet http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatements Revision of Previously Issued Financial Statements Notes 8 false false R9.htm 1009 - Disclosure - Summary of Significant Accounting Policies Sheet http://equ.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 1010 - Disclosure - Public Offering Sheet http://equ.com/role/PublicOffering Public Offering Notes 10 false false R11.htm 1011 - Disclosure - Private Placement Sheet http://equ.com/role/PrivatePlacement Private Placement Notes 11 false false R12.htm 1012 - Disclosure - Related Party Transactions Sheet http://equ.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 1013 - Disclosure - Commitments and Contingencies Sheet http://equ.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 1014 - Disclosure - Stockholders' Equity Sheet http://equ.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 1015 - Disclosure - Warrants Sheet http://equ.com/role/Warrants Warrants Notes 15 false false R16.htm 1016 - Disclosure - Fair Value Measurements Sheet http://equ.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 1017 - Disclosure - Subsequent Events Sheet http://equ.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 1018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://equ.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Revision of Previously Issued Financial Statements (Tables) Sheet http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsTables Revision of Previously Issued Financial Statements (Tables) Tables http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatements 19 false false R20.htm 1020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://equ.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://equ.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 1021 - Disclosure - Fair Value Measurements (Tables) Sheet http://equ.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://equ.com/role/FairValueMeasurements 21 false false R22.htm 1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) Sheet http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail Description of Organization and Business Operations - Additional Information (Detail) Details 22 false false R23.htm 1023 - Disclosure - Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail) Sheet http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail) Details 23 false false R24.htm 1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) Sheet http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail) Details 24 false false R25.htm 1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Public Offering - Additional Information (Detail) Sheet http://equ.com/role/PublicOfferingAdditionalInformationDetail Public Offering - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Private Placement - Additional Information (Detail) Sheet http://equ.com/role/PrivatePlacementAdditionalInformationDetail Private Placement - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://equ.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 29 false false R30.htm 1030 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://equ.com/role/StockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 30 false false R31.htm 1031 - Disclosure - Warrants - Additional Information (Detail) Sheet http://equ.com/role/WarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail) Sheet http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail) Details 32 false false R33.htm 1033 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail) Sheet http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail) Details 33 false false R34.htm 1034 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 34 false false All Reports Book All Reports d198656d10q.htm d198656dex311.htm d198656dex312.htm d198656dex321.htm d198656dex322.htm eqd-20210630.xsd eqd-20210630_cal.xml eqd-20210630_def.xml eqd-20210630_lab.xml eqd-20210630_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true JSON 52 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d198656d10q.htm": { "axisCustom": 4, "axisStandard": 11, "contextCount": 120, "dts": { "calculationLink": { "local": [ "eqd-20210630_cal.xml" ] }, "definitionLink": { "local": [ "eqd-20210630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "d198656d10q.htm" ] }, "labelLink": { "local": [ "eqd-20210630_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "eqd-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "eqd-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 318, "entityCount": 1, "hidden": { "http://equ.com/20210630": 1, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 6 }, "keyCustom": 50, "keyStandard": 199, "memberCustom": 17, "memberStandard": 17, "nsprefix": "eqd", "nsuri": "http://equ.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://equ.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Public Offering", "role": "http://equ.com/role/PublicOffering", "shortName": "Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:InitialPublicOfferingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:PrivatePlacementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Private Placement", "role": "http://equ.com/role/PrivatePlacement", "shortName": "Private Placement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:PrivatePlacementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Related Party Transactions", "role": "http://equ.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Commitments and Contingencies", "role": "http://equ.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Stockholders' Equity", "role": "http://equ.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Warrants", "role": "http://equ.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Fair Value Measurements", "role": "http://equ.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Subsequent Events", "role": "http://equ.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "eqd:RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Revision of Previously Issued Financial Statements (Tables)", "role": "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsTables", "shortName": "Revision of Previously Issued Financial Statements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "eqd:RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance Sheets", "role": "http://equ.com/role/CondensedBalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://equ.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Fair Value Measurements (Tables)", "role": "http://equ.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "eqd:PercentageOfTheTotalPublicSharesTransferrable", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail)", "role": "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "shortName": "Description of Organization and Business Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "eqd:PercentageOfTheTotalPublicSharesTransferrable", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdditionalPaidInCapitalCommonStock", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail)", "role": "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail", "shortName": "Revision of Previously Issued Financial Statements - Schedule Of Error Corrections And Prior Period Adjustments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "eqd:RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn03_31_2021", "decimals": "0", "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "role": "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P04_01_2021To06_30_2021_NonRedeemableCommonStockMemberusgaapStatementClassOfStockAxis", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "div", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "role": "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:UnrecognizedTaxBenefits", "div", "div", "us-gaap:IncomeTaxPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P09_18_2020To09_18_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Public Offering - Additional Information (Detail)", "role": "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "shortName": "Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "eqd:InitialPublicOfferingDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "eqd:PrivatePlacementDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021_PrivatePlacementWarantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "eqd:ClassOfWarrantOrRightPricePerWarrant", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Private Placement - Additional Information (Detail)", "role": "http://equ.com/role/PrivatePlacementAdditionalInformationDetail", "shortName": "Private Placement - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "eqd:PrivatePlacementDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021_PrivatePlacementWarantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "eqd:ClassOfWarrantOrRightPricePerWarrant", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P07_14_2020To07_14_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "eqd:UnderwritingFeePerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://equ.com/role/CommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "eqd:UnderwritingFeePerUnit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance Sheets (Parenthetical)", "role": "http://equ.com/role/CondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Stockholders' Equity - Additional Information (Detail)", "role": "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "shortName": "Stockholders' Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P07_17_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockVotingRights", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "eqd:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:WarrantsAndRightsOutstandingMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Warrants - Additional Information (Detail)", "role": "http://equ.com/role/WarrantsAdditionalInformationDetail", "shortName": "Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "eqd:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:WarrantsAndRightsOutstandingMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "eqd:WarrantLiability", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail)", "role": "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail", "shortName": "Fair Value Measurements - Schedule of Fair Value, Assets Measured on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis", "decimals": "0", "lang": null, "name": "eqd:MarketableSecuritiesHeldInTrustAccountFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1033 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail)", "role": "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail", "shortName": "Fair Value Measurements - Summary of Reconciliation of Warrant Liabilities Measured at Fair Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1034 - Disclosure - Fair Value Measurements - Additional Information (Detail)", "role": "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "shortName": "Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn06_30_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statement of Operations", "role": "http://equ.com/role/CondensedStatementOfOperations", "shortName": "Condensed Statement of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statement of Changes In Stockholders' Equity", "role": "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "shortName": "Condensed Statement of Changes In Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To03_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "0", "lang": null, "name": "us-gaap:StockRedeemedOrCalledDuringPeriodValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statement of Cash Flows", "role": "http://equ.com/role/CondensedStatementOfCashFlows", "shortName": "Condensed Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "lang": null, "name": "eqd:InterestEarnedOnMarketableSecuritiesHeld", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Description of Organization and Business Operations", "role": "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperations", "shortName": "Description of Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Revision of Previously Issued Financial Statements", "role": "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatements", "shortName": "Revision of Previously Issued Financial Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "eqd:RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Summary of Significant Accounting Policies", "role": "http://equ.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d198656d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 35, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "eqd_AccountingChangesAndErrorCorrectionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting changes and error corrections.", "label": "Accounting Changes And Error Corrections [Line Items]" } } }, "localname": "AccountingChangesAndErrorCorrectionsLineItems", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "stringItemType" }, "eqd_AccountingChangesAndErrorCorrectionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting changes and error corrections.", "label": "Accounting Changes And Error Corrections [Table]" } } }, "localname": "AccountingChangesAndErrorCorrectionsTable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "stringItemType" }, "eqd_AccruedExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued expenses.", "label": "Accrued Expenses [Member]" } } }, "localname": "AccruedExpensesMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative support agreement.", "label": "Administrative Support Agreement [Member]" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_AffiliateOfSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliate of sponsor.", "label": "Affiliate Of Sponsor [Member]" } } }, "localname": "AffiliateOfSponsorMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash withdrawn from trust account to pay franchise and income taxes.", "label": "Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes", "terseLabel": "Cash withdrawn from Trust Account to pay franchise and income taxes" } } }, "localname": "CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "eqd_ChangeInValueOfCommonStockSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in value of common stock subject to possible redemption.", "label": "Change In Value Of Common Stock Subject To Possible Redemption", "terseLabel": "Change in value of Class A common stock subject to possible redemption" } } }, "localname": "ChangeInValueOfCommonStockSubjectToPossibleRedemption", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "eqd_ClassOfWarrantOrRightPricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right, price per warrant.", "label": "Class of Warrant or Right Price Per Warrant", "terseLabel": "Class of warrant or right, price per warrant" } } }, "localname": "ClassOfWarrantOrRightPricePerWarrant", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_ClassOfWarrantsExercisePriceAdjustmentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants exercise price adjustment percentage.", "label": "Class Of Warrants Exercise Price Adjustment Percentage", "terseLabel": "Class of warrants exercise price adjustment percentage" } } }, "localname": "ClassOfWarrantsExercisePriceAdjustmentPercentage", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_ClassOfWarrantsOrRightsIssuePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issue price per share.", "label": "Class Of Warrants Or Rights Issue Price Per Share", "terseLabel": "Class of warrants or rights issue price per share" } } }, "localname": "ClassOfWarrantsOrRightsIssuePricePerShare", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_CommonStockSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock subject to possible redemption.", "label": "Common Stock Subject To Possible Redemption [Member]" } } }, "localname": "CommonStockSubjectToPossibleRedemptionMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "eqd_ConditionToEffectBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition to effect business combination.", "label": "Condition To Effect Business Combination [Member]", "terseLabel": "Condition To Effect Business Combination [Member]" } } }, "localname": "ConditionToEffectBusinessCombinationMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_DateBeforeWhichTheBusinessCombinationMustBeConsummated": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date before which the business combination must be consummated.", "label": "Date Before Which The Business Combination Must Be Consummated", "terseLabel": "Date before which the business combination is to be consumated" } } }, "localname": "DateBeforeWhichTheBusinessCombinationMustBeConsummated", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "eqd_DeferredUnderwritingCommissionsPercentagePayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions percentage payable.", "label": "Deferred Underwriting Commissions Percentage Payable", "terseLabel": "Deferred underwriting commissions percentage payable" } } }, "localname": "DeferredUnderwritingCommissionsPercentagePayable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_DeferredUnderwritingFeePayableNoncurrent": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fee payable, noncurrent.", "label": "Deferred Underwriting Fee Payable Noncurrent", "terseLabel": "Deferred underwriting fee payable" } } }, "localname": "DeferredUnderwritingFeePayableNoncurrent", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "eqd_DeferredUnderwritingFeesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fees payable.", "label": "Deferred Underwriting Fees Payable", "terseLabel": "Deferred underwriting fees payable" } } }, "localname": "DeferredUnderwritingFeesPayable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "eqd_DeferredUnderwritingFeesPayableNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriting fees payable non current.", "label": "Deferred Underwriting Fees Payable Non Current", "terseLabel": "Deferred underwriting fees payable non current" } } }, "localname": "DeferredUnderwritingFeesPayableNonCurrent", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "eqd_DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Denominator weighted average common stock subject to possible redemption.", "label": "Denominator Weighted Average Common Stock Subject To Possible Redemption [Abstract]", "verboseLabel": "Denominator: Weighted Average Common stock subject to possible redemption" } } }, "localname": "DenominatorWeightedAverageCommonStockSubjectToPossibleRedemptionAbstract", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "eqd_DisclosureOfPrivatePlacementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of private placement.", "label": "Disclosure Of Private Placement [Line Items]" } } }, "localname": "DisclosureOfPrivatePlacementLineItems", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_DisclosureOfPrivatePlacementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of private placement.", "label": "Disclosure Of Private Placement [Table]" } } }, "localname": "DisclosureOfPrivatePlacementTable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_DisclosureOfPublicOfferingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of public offering.", "label": "Disclosure Of Public Offering [Line Items]" } } }, "localname": "DisclosureOfPublicOfferingLineItems", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_DisclosureOfPublicOfferingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of public offering.", "label": "Disclosure Of Public Offering [Table]" } } }, "localname": "DisclosureOfPublicOfferingTable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_EarningsPerShareBasicAndDilutedCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings per share basic and diluted common stock subject to repurchase or cancellation.", "label": "Earnings Per Share Basic And Diluted Common Stock Subject To Repurchase Or Cancellation", "verboseLabel": "Basic and diluted net (loss) income per share, Common stock subject to possible redemption" } } }, "localname": "EarningsPerShareBasicAndDilutedCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "perShareItemType" }, "eqd_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging growth company [Policy text block].", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "eqd_EquityDistributorSponsorLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity distributor sponsor LLC.", "label": "Equity Distributor Sponsor LLC [Member]", "terseLabel": "Equity Distributor Sponsor LLC [Member]" } } }, "localname": "EquityDistributorSponsorLlcMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_EventsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Events.", "label": "Events [Axis]" } } }, "localname": "EventsAxis", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_EventsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Events.", "label": "Events [Domain]" } } }, "localname": "EventsDomain", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_IncomeTaxCarryBackActLossesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Carry Back Act Losses [Axis]" } } }, "localname": "IncomeTaxCarryBackActLossesAxis", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_IncomeTaxCarryBackActLossesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Carry Back Act Losses [Domain]" } } }, "localname": "IncomeTaxCarryBackActLossesDomain", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_InitialPublicOfferingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering disclosure.", "label": "Initial Public Offering Disclosure [Text Block]", "terseLabel": "Public Offering" } } }, "localname": "InitialPublicOfferingDisclosureTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PublicOffering" ], "xbrltype": "textBlockItemType" }, "eqd_InterestAvailableToBeWithdrawnForPaymentOfTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "interest available to be withdrawn for payment of taxes.", "label": "Interest Available To Be Withdrawn For Payment Of Taxes", "terseLabel": "Less: Interest available to be withdrawn for payment of taxes" } } }, "localname": "InterestAvailableToBeWithdrawnForPaymentOfTaxes", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "eqd_InterestEarnedOnMarketableSecuritiesHeld": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest earned on marketable securities held in Trust Account.", "label": "Interest Earned On Marketable Securities Held", "negatedLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InterestEarnedOnMarketableSecuritiesHeld", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "eqd_LockInPeriodOfShareholding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock in period of shareholding.", "label": "Lock In Period Of Shareholding", "terseLabel": "Lock in period of shareholding" } } }, "localname": "LockInPeriodOfShareholding", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_MarketableSecuritiesHeldInTrustAccountFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Marketable securities held in trust account fair value disclosure.", "label": "Marketable Securities Held In Trust Account Fair Value Disclosure", "terseLabel": "Marketable securities held in Trust Account" } } }, "localname": "MarketableSecuritiesHeldInTrustAccountFairValueDisclosure", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "eqd_MarketableSecuritiesHeldInTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable securities held in trust.", "label": "Marketable Securities Held In Trust [Member]" } } }, "localname": "MarketableSecuritiesHeldInTrustMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "eqd_MinimumCommonStockSharesToBeMaintained": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum common stock shares to be maintained.", "label": "Minimum Common Stock Shares To Be Maintained", "terseLabel": "Minimum common stock shares to be maintained" } } }, "localname": "MinimumCommonStockSharesToBeMaintained", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_MinimumNoticePeriodForWarrantsRedemption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum notice period for warrants redemption.", "label": "Minimum Notice Period For Warrants Redemption", "terseLabel": "Minimum notice period for warrants redemption" } } }, "localname": "MinimumNoticePeriodForWarrantsRedemption", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_MinimumSharePriceRequiredForRedemptionOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum share price required for redemption of warrants.", "label": "Minimum Share Price Required For Redemption Of Warrants", "terseLabel": "Minimum share price required for redemption of warrants" } } }, "localname": "MinimumSharePriceRequiredForRedemptionOfWarrants", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_NatureOfOrganisationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of organisation.", "label": "Nature Of Organisation [Line Items]" } } }, "localname": "NatureOfOrganisationLineItems", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_NatureOfOrganisationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of organisation.", "label": "Nature Of Organisation [Table]" } } }, "localname": "NatureOfOrganisationTable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_NonRedeemableCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non redeemable common stock.", "label": "Non Redeemable Common Stock [Member]" } } }, "localname": "NonRedeemableCommonStockMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "eqd_NumberOfBusinessDaysAfterTheExpiryDateWithinWhichPublicSharesShallBeRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of business days after the expiry date within which public shares shall be redeemed.", "label": "Number Of Business Days After The Expiry Date Within Which Public Shares Shall Be Redeemed", "terseLabel": "Number of business days after the expiry date within which public shares shall be redeemed" } } }, "localname": "NumberOfBusinessDaysAfterTheExpiryDateWithinWhichPublicSharesShallBeRedeemed", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_NumberOfDaysForAParticularEventToGetOverToDetermineShareTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days for a particular event to get over to determine share trading days.", "label": "Number Of Days For A Particular Event To Get Over To Determine Share Trading Days", "terseLabel": "Number of days for a particular event to get over for determning trading period" } } }, "localname": "NumberOfDaysForAParticularEventToGetOverToDetermineShareTradingDays", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_NumberOfDaysUntillWhichWarrantsWillNotBecomeTransferableOrSalable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of days un till which warrants will not become transferable or salable.", "label": "Number of days untill which warrants will not become transferable or salable", "terseLabel": "Number of days untill which warrants will not become transferable or salable" } } }, "localname": "NumberOfDaysUntillWhichWarrantsWillNotBecomeTransferableOrSalable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_NumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares common stock subject to repurchase or cancellation.", "label": "Number Of Shares Common Stock Subject To Repurchase Or Cancellation", "verboseLabel": "Common Stock Subject To Repurchase Or Cancellation" } } }, "localname": "NumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "eqd_NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerator earnings allocable to common stock subject to possible redemption.", "label": "Numerator Earnings Allocable To Common Stock Subject To Possible Redemption [Abstract]", "verboseLabel": "Numerator: Earnings allocable to Class A common stock subject to possible redemption" } } }, "localname": "NumeratorEarningsAllocableToCommonStockSubjectToPossibleRedemptionAbstract", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "eqd_NumeratorNetIncomeLossAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Numerator net income loss attributable to parent .", "label": "Numerator Net Income Loss Attributable To Parent [Abstract]", "verboseLabel": "Numerator: Net (loss) income minus Net Earnings" } } }, "localname": "NumeratorNetIncomeLossAttributableToParentAbstract", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "eqd_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "eqd_PerShareAmountOfAssetsAvailableForDistribution": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount of assets available for distribution.", "label": "Per Share Amount Of Assets Available For Distribution", "terseLabel": "Per share amount of assets available for distribution" } } }, "localname": "PerShareAmountOfAssetsAvailableForDistribution", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_PercentageOfCommonStockShareholding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common stock shareholding.", "label": "Percentage Of Common Stock Shareholding", "terseLabel": "Percentage of common stock shareholding" } } }, "localname": "PercentageOfCommonStockShareholding", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_PercentageOfProceedsFromShareIssuances": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of proceeds from share issuances.", "label": "Percentage Of Proceeds From Share Issuances", "terseLabel": "Percentage of proceeds from share issuances" } } }, "localname": "PercentageOfProceedsFromShareIssuances", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_PercentageOfTheFairValueOfTheAmountHeldInTrustAccountNetOfIncomeTaxesAndDeferredUnderwritingCommissionsOfTheProposedAcquiree": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the fair value of the amount held in trust account net of income taxes and deferred underwriting commissions of the proposed acquiree.", "label": "Percentage Of The Fair Value Of The Amount Held In Trust Account Net Of Income Taxes And Deferred Underwriting Commissions Of The Proposed Acquiree", "terseLabel": "Percentage of the fair value of the amount held in trust account excluding deferred underwriting commissions and income taxes" } } }, "localname": "PercentageOfTheFairValueOfTheAmountHeldInTrustAccountNetOfIncomeTaxesAndDeferredUnderwritingCommissionsOfTheProposedAcquiree", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_PercentageOfThePublicSharesDueToBeRedeemedOnNonOccurrenceOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the public shares due to be redeemed on non occurrence of business combination.", "label": "Percentage Of The Public Shares Due To Be Redeemed On Non Occurrence Of Business Combination", "terseLabel": "Percentage of public shares due to be redeemed on non occurrence of business combination" } } }, "localname": "PercentageOfThePublicSharesDueToBeRedeemedOnNonOccurrenceOfBusinessCombination", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_PercentageOfTheTotalPublicSharesTransferrable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of the total public shares transferrable.", "label": "Percentage Of The Total Public Shares Transferrable", "terseLabel": "Percentage of the total public shares transferrable" } } }, "localname": "PercentageOfTheTotalPublicSharesTransferrable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "eqd_PrivatePlacementDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement disclosure.", "label": "Private Placement Disclosure [Text Block]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementDisclosureTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PrivatePlacement" ], "xbrltype": "textBlockItemType" }, "eqd_PrivatePlacementWarantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warants.", "label": "Private Placement Warants [Member]", "terseLabel": "Private Placement Warants [Member]" } } }, "localname": "PrivatePlacementWarantsMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PrivatePlacementAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrants.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "eqd_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private warrants [Member].", "label": "Private Warrants [Member]", "verboseLabel": "Private Warrants [Member]" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "eqd_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public warrants.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_RecentlyIssuedAccountingStandardNotYetEffectivePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recently issued accounting standard not yet effective [Policy text block].", "label": "Recently Issued Accounting Standard Not Yet Effective [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "RecentlyIssuedAccountingStandardNotYetEffectivePolicyTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "eqd_ReclassificationOfNetIncomeLossPerCommonSharePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification of net income loss per common share.", "label": "Reclassification Of Net Income Loss Per Common Share [Policy Text Block]", "verboseLabel": "Reconciliation of Net Income (Loss) per Common Share" } } }, "localname": "ReclassificationOfNetIncomeLossPerCommonSharePolicyTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "eqd_RedemptionValuePerShareCommonStockExcludingDeferredUnderwritingCommissionsAndIncomeTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption value per share common stock excluding deferred underwriting commissions and income taxes.", "label": "Redemption Value Per Share Common Stock Excluding Deferred Underwriting Commissions And Income Taxes", "terseLabel": "Redemption value per share,common stock" } } }, "localname": "RedemptionValuePerShareCommonStockExcludingDeferredUnderwritingCommissionsAndIncomeTaxes", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term", "label": "Restricted Investments Term", "terseLabel": "Restricted investments term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_RestrictionOfShareTransferabilityOnApprovalOfBusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restriction of share transferability on approval of business combination.", "label": "Restriction Of Share Transferability On Approval Of Business Combination [Member]", "terseLabel": "Restriction Of Share Transferability On Approval Of Business Combination [Member]" } } }, "localname": "RestrictionOfShareTransferabilityOnApprovalOfBusinessCombinationMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_RevisionOfPreviouslyIssuedFinancialStatementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revision of previously issued financial statements.", "label": "Revision of Previously Issued Financial Statements [Text Block]", "terseLabel": "Revision of Previously Issued Financial Statements" } } }, "localname": "RevisionOfPreviouslyIssuedFinancialStatementsTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "eqd_ScheduleOfFinancialInstrumentsSubjectToPossibleRedemptionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of financial instruments subject to possible redemption.", "label": "Schedule Of Financial Instruments Subject To Possible Redemption [Axis]" } } }, "localname": "ScheduleOfFinancialInstrumentsSubjectToPossibleRedemptionAxis", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "eqd_ScheduleOfFinancialInstrumentsSubjectToPossibleRedemptionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of financial instruments subject to possible redemption.", "label": "Schedule Of Financial Instruments Subject To Possible Redemption [Domain]" } } }, "localname": "ScheduleOfFinancialInstrumentsSubjectToPossibleRedemptionDomain", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "eqd_SecondPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Promissory Note .", "label": "Second Promissory Note [Member]" } } }, "localname": "SecondPromissoryNoteMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_SecuritiesHeldInTrustAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities held in trust.", "label": "Securities Held In Trust [Axis]" } } }, "localname": "SecuritiesHeldInTrustAxis", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "eqd_SecuritiesHeldInTrustDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities held in trust.", "label": "Securities Held In Trust [Domain]" } } }, "localname": "SecuritiesHeldInTrustDomain", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "domainItemType" }, "eqd_ShareTransferRestrictionThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share transfer restriction, threshold consecutive trading days.", "label": "Share Transfer Restriction Threshold Consecutive Trading Days", "terseLabel": "Share transfer restriction, threshold consecutive trading days" } } }, "localname": "ShareTransferRestrictionThresholdConsecutiveTradingDays", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_ShareTransferRestrictionThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share transfer restriction, threshold trading days.", "label": "Share Transfer Restriction Threshold Trading Days", "terseLabel": "Share transfer restriction, threshold trading days" } } }, "localname": "ShareTransferRestrictionThresholdTradingDays", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_ShareTriggerPriceOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share trigger price one.", "label": "Share Trigger Price One [Member]" } } }, "localname": "ShareTriggerPriceOneMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_ShareTriggerPriceTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share trigger price two.", "label": "Share Trigger Price Two [Member]" } } }, "localname": "ShareTriggerPriceTwoMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_SignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Line Items]" } } }, "localname": "SignificantAccountingPoliciesLineItems", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_SignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Table]" } } }, "localname": "SignificantAccountingPoliciesTable", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor.", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "eqd_StockRelatedWarrantsIssuedDuringThePeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock related warrants issued during the period, shares.", "label": "Stock Related Warrants Issued During The Period Shares", "terseLabel": "Stock related warrants issued during the period shares" } } }, "localname": "StockRelatedWarrantsIssuedDuringThePeriodShares", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "eqd_TemporaryEquityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity [Policy text block].", "label": "Temporary Equity [Policy Text Block]", "terseLabel": "Class\u00a0A Common Stock Subject to Possible Redemption" } } }, "localname": "TemporaryEquityPolicyTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "eqd_TriggeringEventAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering event.", "label": "Triggering Event [Axis]" } } }, "localname": "TriggeringEventAxis", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "eqd_TriggeringEventDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Triggering event.", "label": "Triggering Event [Domain]" } } }, "localname": "TriggeringEventDomain", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "eqd_UnderwritingFeePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting fee, per unit.", "label": "Underwriting Fee Per Unit", "terseLabel": "Underwriting fee, per unit" } } }, "localname": "UnderwritingFeePerUnit", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_UnderwritingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriting fees.", "label": "Underwriting Fees", "terseLabel": "Undrwriting fees" } } }, "localname": "UnderwritingFees", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "eqd_WarrantLiability": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability.", "label": "Warrant Liability", "verboseLabel": "Warrant liability" } } }, "localname": "WarrantLiability", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "eqd_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant liability [Policy Text Block].", "label": "Warrant Liability [Policy Text Block]", "terseLabel": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "eqd_WarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Abstract].", "label": "Warrants [Abstract]" } } }, "localname": "WarrantsAbstract", "nsuri": "http://equ.com/20210630", "xbrltype": "stringItemType" }, "eqd_WarrantsAndRightsOutstandingMaturityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights outstanding maturity period.", "label": "Warrants And Rights Outstanding Maturity Period", "terseLabel": "Public warrants expiry period" } } }, "localname": "WarrantsAndRightsOutstandingMaturityPeriod", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_WarrantsRedeemablethresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants redeemable,threshold consecutive trading days", "label": "Warrants RedeemableThreshold Consecutive Trading Days", "terseLabel": "Warrants redeemable,threshold consecutive trading days" } } }, "localname": "WarrantsRedeemablethresholdConsecutiveTradingDays", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "eqd_WarrantsRedemptionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants, redemption price per share.", "label": "Warrants Redemption Price Per Share", "terseLabel": "Warrants, redemption price per share" } } }, "localname": "WarrantsRedemptionPricePerShare", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "eqd_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Text Block].", "label": "Warrants [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://equ.com/20210630", "presentation": [ "http://equ.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "srt_MaximumMember": { "auth_ref": [ "r150", "r152", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r150", "r152", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r140", "r150", "r152", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r140", "r150", "r152", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r67", "r68", "r70", "r71", "r84" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r67", "r68", "r69", "r70", "r71", "r84", "r112", "r113", "r157", "r169", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r67", "r68", "r69", "r70", "r71", "r84", "r112", "r113", "r157", "r169", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r57", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r67", "r68", "r70", "r71", "r84", "r112", "r113", "r157", "r169", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r120", "r151", "r209" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Current liability, accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r12" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional\u00a0paid-in\u00a0capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r57", "r58", "r60", "r154", "r155", "r156" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r122", "r129", "r136" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "verboseLabel": "Stock related warrants issued during the period value" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from the computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r51", "r100", "r102", "r106", "r110", "r172", "r174", "r191", "r236", "r243" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r25", "r51", "r110", "r172", "r174", "r191" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Marketable securities held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r176", "r177" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business acquisition, share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r17", "r262", "r263" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r17", "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash \u2013 End of period", "periodStartLabel": "Cash \u2013 Beginning of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net Change in Cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r7", "r45", "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r7", "r45", "r48", "r235" ], "lang": { "en-us": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "Cash insured with federal insurance" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r49", "r51", "r74", "r75", "r76", "r79", "r81", "r86", "r87", "r88", "r110", "r191" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage", "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r138", "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail", "http://equ.com/role/PrivatePlacementAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail", "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail", "http://equ.com/role/PrivatePlacementAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Excerice price of warrants", "verboseLabel": "Warrants exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail", "http://equ.com/role/PrivatePlacementAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "verboseLabel": "Number Of Securities Called By Each Warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/PrivatePlacementAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r138", "r153" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r22", "r119", "r238", "r246" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r116", "r117", "r118", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage", "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r57", "r58" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock Authorized", "verboseLabel": "Common Stock Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock issued", "verboseLabel": "Common Stock Shares Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock Outstanding", "verboseLabel": "Common Stock Shares Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Common stock description of voting rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r92", "r242" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r46", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Conversion of debt into warrants value" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Converion price per unit of debt into warrant" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r198", "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount", "terseLabel": "Debt instrument unused borrowing capacity" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net (loss) income per share, Non-redeemable common stock", "verboseLabel": "Basic and diluted net income (loss) per share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r48", "r82", "r83" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r57", "r58", "r60", "r62", "r68", "r71", "r85", "r111", "r129", "r136", "r154", "r155", "r156", "r168", "r169", "r192", "r193", "r194", "r195", "r196", "r197", "r252", "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r42", "r124" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://equ.com/role/CondensedStatementOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liability", "terseLabel": "Change in fair value of warrant liability" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets Measured on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r178", "r189", "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r149", "r179", "r211", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r178", "r179", "r180", "r181", "r186" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]" } } }, "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value.", "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]" } } }, "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r141", "r142", "r147", "r149", "r179", "r211" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r141", "r142", "r147", "r149", "r179", "r212" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r182", "r185" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r182", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Reconciliation of Warrant Liabilities Measured at Fair Value" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in valuation inputs or other assumptions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value as of June 30, 2021", "periodStartLabel": "Fair value as of December 31, 2020" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r149", "r211", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r183", "r186" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsSummaryOfReconciliationOfWarrantLiabilitiesMeasuredAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r48", "r187", "r188" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]" } } }, "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r29", "r100", "r101", "r104", "r105", "r107", "r234", "r239", "r241", "r248" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "(Loss) Income before benefit from (provision for) income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r52", "r70", "r71", "r99", "r161", "r170", "r171", "r249" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r28", "r48", "r159", "r160", "r164", "r165", "r166", "r167", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r41" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r41" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseOfRestrictedInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or outflow for the increase (decrease) associated with investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Increase (Decrease) of Restricted Investments", "terseLabel": "Unrealized loss on investments held in Trust Account" } } }, "localname": "IncreaseDecreaseOfRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r32", "r34" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail": { "order": 2.0, "parentTag": "us-gaap_TemporaryEquityDividendsAdjustment", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Interest earned on marketable securities held in Trust Account", "verboseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r51", "r103", "r110", "r173", "r174", "r175", "r191" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r51", "r110", "r191", "r237", "r245" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsScheduleOfFairValueAssetsMeasuredOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities": { "auth_ref": [ "r1" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated accrued costs to dispose of assets or other items expected to be sold in liquidation.", "label": "Liquidation Basis of Accounting, Accrued Costs to Dispose of Assets and Liabilities", "terseLabel": "Estimated liquidation expenses payable" } } }, "localname": "LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r31" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Marketable Securities, Unrealized Gain (Loss)", "terseLabel": "Unrealized loss on marketable securities held in Trust Account" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r265", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The lowest amount of net worth (total assets minus total liabilities) required by secondary market investors or state-imposed regulatory mandates.", "label": "Minimum Net Worth Required for Compliance", "terseLabel": "Estimated minimum networth of the combined companies post business combination" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r89", "r98" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Description of Organization and Business Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r39" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r39" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r39", "r40", "r43" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r26", "r27", "r30", "r43", "r51", "r61", "r63", "r64", "r65", "r66", "r70", "r71", "r77", "r100", "r101", "r104", "r105", "r107", "r110", "r191", "r240", "r247" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://equ.com/role/CondensedStatementOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Net income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "presentationGuidance": "Net (loss) income", "totalLabel": "Net (loss) income", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CondensedStatementOfOperations", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r73", "r78", "r81" ], "calculation": { "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Non-Redeemable net (loss) income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-Cash Investing and Financing Activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r33" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Other (expense) income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r18", "r55", "r204" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Promissory note \u2013 related party" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "terseLabel": "Operating and formation costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r100", "r101", "r104", "r105", "r107" ], "calculation": { "http://equ.com/role/CondensedStatementOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireRestrictedInvestments": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.", "label": "Payments to Acquire Restricted Investments", "verboseLabel": "Payment towards restricted investments" } } }, "localname": "PaymentsToAcquireRestrictedInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock Par value", "verboseLabel": "Preferred stock par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock Authorized", "verboseLabel": "Preferred Stock Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock issued", "verboseLabel": "Preferred Stock Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock Outstanding", "verboseLabel": "Preferred stock outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r114", "r115" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r36" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from initial public offer" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r36" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "verboseLabel": "Proceeds From issue of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r37" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from promissory note \u2013 related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCommonRedemptionValue": { "auth_ref": [ "r126" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redemption value, as if currently redeemable, of redeemable noncontrolling interest for common shares, units or ownership interests classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.", "label": "Redeemable Noncontrolling Interest, Equity, Common, Redemption Value", "terseLabel": "Class A common stock subject to possible redemption 36,947,842 and 35,856,659 at redemption value as of June 30, 2021 and December 31, 2020, respectively" } } }, "localname": "RedeemableNoncontrollingInterestEquityCommonRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Noncontrolling Interest, Equity, Redemption Value [Abstract]", "verboseLabel": "Non-Redeemable Common Stock" } } }, "localname": "RedeemableNoncontrollingInterestEquityRedemptionValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r148", "r202", "r203" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r202", "r205" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party transaction amounts of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r148", "r202", "r203", "r205" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r148", "r202", "r205", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r200", "r201", "r203", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "terseLabel": "Repayment of notes payable" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r136", "r157", "r244", "r256", "r261" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r57", "r58", "r60", "r62", "r68", "r71", "r111", "r154", "r155", "r156", "r168", "r169", "r252", "r254" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings/ (Accumulated Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock issue price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "auth_ref": [ "r69", "r70", "r71" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.", "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Schedule Of Error Corrections And Prior Period Adjustments" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r53", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r23", "r49", "r86", "r87", "r125", "r127", "r128", "r130", "r131", "r132", "r133", "r134", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r9", "r10", "r11", "r49", "r51", "r74", "r75", "r76", "r79", "r81", "r86", "r87", "r88", "r110", "r129", "r191" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage", "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail", "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail", "http://equ.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r57", "r58", "r60", "r62", "r68", "r71", "r85", "r111", "r129", "r136", "r154", "r155", "r156", "r168", "r169", "r192", "r193", "r194", "r195", "r196", "r197", "r252", "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r57", "r58", "r60", "r85", "r221" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/CondensedStatementOfCashFlows", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "verboseLabel": "Stock issued during the period shares issued for shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r11", "r129", "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock shares issued during the period shares new issues", "verboseLabel": "Stock shares issued during the period shares new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r10", "r11", "r129", "r136" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "terseLabel": "Stock issued during the period shares Stock Splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "verboseLabel": "Stock issued during the period value for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "negatedLabel": "Change in value of Class A common stock subject to possible redemption, shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "negatedLabel": "Change in value of Class A common stock subject to possible redemption" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r14", "r15", "r51", "r108", "r110", "r191" ], "calculation": { "http://equ.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets", "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/RevisionOfPreviouslyIssuedFinancialStatementsScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r50", "r136", "r139" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplit": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.", "label": "Stockholders' Equity Note, Stock Split", "terseLabel": "Stock split ratio" } } }, "localname": "StockholdersEquityNoteStockSplit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders' Equity, Reverse Stock Split", "terseLabel": "Reserve stock split ratio" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r208", "r210" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfChangesInStockholdersEquity", "http://equ.com/role/DescriptionOfOrganizationAndBusinessOperationsAdditionalInformationDetail", "http://equ.com/role/PublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityDividendsAdjustment": { "auth_ref": [], "calculation": { "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).", "label": "Temporary Equity, Dividends, Adjustment", "negatedLabel": "Add: Net loss allocable to Class A common stock subject to possible redemption", "totalLabel": "Net (loss) income attributable" } } }, "localname": "TemporaryEquityDividendsAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Ordinary shares subject to possible redemption shares", "verboseLabel": "Common stock subject to possible redemption" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedBalanceSheetsParenthetical", "http://equ.com/role/StockholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r42" ], "calculation": { "http://equ.com/role/CondensedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Unrealized loss on marketable securities held in Trust Account" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r158", "r163" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognised tax liabilities" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r162" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognised tax liabilities accrued penalties and interest" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r90", "r91", "r93", "r94", "r95", "r96", "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Warrants outstanding" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/FairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Basic and diluted weighted average shares outstanding, Non-redeemable common stock", "verboseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations", "http://equ.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfEarningsPerShareBasicAndDilutedDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation", "verboseLabel": "Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://equ.com/role/CondensedStatementOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=95464943&loc=SL35686261-199414" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "24(b)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL7498357-110258" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r268": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r269": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r270": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r271": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r272": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r273": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r274": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" } }, "version": "2.1" } ZIP 53 0001193125-21-239407-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-239407-xbrl.zip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b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